
Advertise on podcast: Tick Boot Camp
Rating
5from
This podcast has
623 episodes
Language
EnglishPublisher
Matt Sabatello and Rich JohannesenExplicit
No
Date created
2018/10/06
Latest episode
2026/11/17
Average duration
28 min.
Release period
2 days
Description
The goal of the Tick Boot Camp Podcast is to help people liberate themselves and others from suffering caused by Lyme disease through validation, community building, belief that healing is possible, and modeling success. Listen to our Tick Boot Camp podcast using all major podcast streaming services such as Apple Podcasts, Spotify, and YouTube Music. Our podcast is also integrated with smart home devices, such as Amazon Alexa and Apple TV. Ask your device to "play the Tick Boot Camp Podcast!"
Unlock Tick Boot Camp podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Social media
Check Tick Boot Camp social media presence
Podcast episodes
Check latest episodes from Tick Boot Camp podcast
Beyond Lyme Disease: Bartonella, Babesia & Whole-Body Healing – Dr. Meagan McLaughlin | LIVE from ILADS
2026/11/17
Could Lyme disease, Bartonella, or Babesia be contributing to symptoms that have been attributed to fibromyalgia, hormonal changes, chronic fatigue, or other conditions? And why might addressing an infection be only one part of a patient's recovery journey?
In this LIVE from ILADS episode of the Tick Boot Camp Podcast, co-host Rich Johannesen interviews Dr. Meagan McLaughlin, DNP, FNP-C, IFMCP, a functional medicine nurse practitioner at Aurora Integrative Medical Clinic in Mount Vernon, Iowa.
Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation explores the growing recognition of tick-borne diseases in the Midwest, the complexity of Lyme disease and coinfections, and the importance of a comprehensive, individualized approach to patient care.
Dr. McLaughlin discusses her experience evaluating patients with Lyme disease, Bartonella, Babesia, anaplasmosis, and tick-borne relapsing fever. She also explains why her clinical assessments extend beyond infectious disease testing to consider nutrition, gastrointestinal health, hormones, thyroid function, sleep, and other factors that can influence overall health.
But one of the most important themes of the conversation is the relationship between patients and healthcare professionals.
Dr. McLaughlin believes that patients should be active partners in their healthcare, understand why treatments are recommended, and feel empowered to participate in decisions about their recovery.
Together, Rich and Dr. McLaughlin explore how education, communication, comprehensive medical histories, and collaborative care can help transform the patient experience.
Meet Dr. Meagan McLaughlin, DNP, FNP-C, IFMCP
Dr. Meagan McLaughlin is an advanced nurse practitioner specializing in functional and integrative medicine at Aurora Integrative Medical Clinic in Mount Vernon, Iowa, near Cedar Rapids and Iowa City.
Originally from Anchorage, Alaska, she eventually settled in Iowa, where she developed an interest in autoimmune disease, chronic illness, and the potential role of infections and environmental factors in complex medical conditions.
Dr. McLaughlin earned her Doctor of Nursing Practice degree at Clarke University and is certified through the Institute for Functional Medicine.
Her professional interests include:
Lyme disease and associated tick-borne infections
Autoimmune conditions
Chronic inflammatory illnesses
Thyroid and hormone dysfunction
Nutritional and gastrointestinal health
Integrative and functional medicine
Individualized approaches to complex chronic illness
She has also completed physician training through ILADS and participates in continuing education related to Lyme disease and associated conditions.
Learn more about her background through the clinic's official provider biographies.
How Autoimmune Disease Led Her to Functional Medicine
Dr. McLaughlin explains that her interest in functional medicine began with her family's experiences.
Several family members had autoimmune conditions, and her daughter was diagnosed with an autoimmune illness at a young age.
These experiences motivated her to investigate why certain individuals develop chronic illnesses.
She became interested in genetics, environmental exposures, immune regulation, and other factors that may influence disease.
As she expanded her education, she began exploring the potential role of infections, including tick-borne pathogens, in some complex clinical presentations.
This eventually led her to ILADS and additional training in Lyme disease and associated infections.
Dr. McLaughlin emphasizes the importance of continuing education and remaining open to new information when patients are not improving.
Lyme Disease in Iowa: Why Tick-Borne Illness Isn't Just a Northeast Problem
Rich asks Dr. McLaughlin about the patients she encounters in Iowa.
Although Lyme disease is often associated with the Northeast, tick-borne infections are also important public health concerns in parts of the Midwest.
Dr. McLaughlin explains that her practice serves a diverse population.
Some patients live in rural communities, work on farms, hunt, or spend substantial time outdoors.
Others come from suburban areas, college communities, and nearby cities.
She describes seeing patients from Mount Vernon, Cedar Rapids, Iowa City, and surrounding communities.
Her experience challenges the assumption that tick-borne diseases affect only people who regularly hike or spend time in wooded environments.
Tick exposure can occur in many everyday outdoor settings, including residential yards.
Lyme Disease Symptoms That Can Resemble Other Conditions
Dr. McLaughlin discusses the wide range of symptoms she encounters among patients being evaluated for possible tick-borne infections.
Some report persistent fatigue, insomnia, joint pain, or generalized aches.
Others experience more complicated symptoms involving the nervous system or cardiovascular system.
Examples discussed include:
Chronic fatigue
Joint and muscle pain
Symptoms resembling fibromyalgia
Sleep disturbances
Brain fog and cognitive difficulties
Heart palpitations
Postural orthostatic tachycardia syndrome (POTS)
Autonomic nervous system dysfunction
Symptoms that overlap with perimenopause
Recurrent or severe illness episodes
Dr. McLaughlin describes Lyme disease as a condition that can sometimes be difficult to recognize because its symptoms overlap with other illnesses.
However, these symptoms are not specific to Lyme disease. POTS, fibromyalgia, hormonal changes, thyroid disorders, autoimmune diseases, and other conditions can have independent causes.
A comprehensive medical evaluation is important to determine which diagnoses are supported by a patient's history, examination, and appropriate testing.
Beyond Borrelia: Bartonella, Babesia, and Other Tick-Borne Infections
One of the central topics is the possibility of multiple infections.
Rich discusses how Tick Boot Camp guests increasingly describe complex diagnostic histories involving several organisms.
He refers to the three Bs:
Borrelia, Bartonella, and Babesia.
Dr. McLaughlin explains that her practice evaluates patients for multiple tick-borne pathogens when clinically appropriate.
She discusses encountering patients with laboratory findings involving:
Borrelia: Bacteria associated with Lyme disease and certain relapsing fever illnesses
Babesia: Parasites that infect red blood cells and cause babesiosis
Bartonella: Bacteria associated with several human diseases, including cat-scratch disease
Anaplasma: Bacteria responsible for human granulocytic anaplasmosis
Tick-borne relapsing fever pathogens: Borrelia species associated with relapsing fever
She particularly highlights Babesia and anaplasmosis among infections encountered in her regional patient population.
Dr. McLaughlin also discusses the importance of considering travel and exposure histories, including connections between Iowa, Wisconsin, and Minnesota.
During the interview, she estimates that a high percentage of patients selected for testing in her specialty practice have positive findings.
These figures reflect her experience with a highly selected clinical population and should not be interpreted as infection prevalence in Iowa or the general public.
Likewise, multiple positive laboratory findings do not automatically establish multiple active infections. Each result requires appropriate clinical interpretation.
Understanding Lyme Disease and Coinfection Testing
Dr. McLaughlin describes using specialized laboratory testing as part of her clinical evaluations.
She mentions IGeneX and ArminLabs as laboratories her practice has used.
Her approach emphasizes gathering information that may help guide individualized treatment decisions.
She also explains that some patients undergo additional testing over time as their clinical picture changes.
Not all Lyme disease or coinfection tests have the same clinical validation, sensitivity, or specificity.
Testing methods should be selected according to the suspected infection, symptoms, exposure history, and current diagnostic guidance.
For Lyme disease, validated two-tier antibody testing remains an important diagnostic approach. Other infections, including babesiosis and anaplasmosis, may require different laboratory methods.
A positive test does not always establish active infection, and a negative result must be interpreted in the context of the disease being evaluated.
Learn more through Tick Boot Camp's Lyme Disease Testing Resource.
Why Treating Lyme Disease May Require Looking at the Whole Patient
Dr. McLaughlin explains that her approach to complex chronic illness involves more than identifying possible pathogens.
She also considers factors that may influence a patient's symptoms, general health, and ability to tolerate treatment.
These include:
Nutritional status
Sleep quality
Thyroid function
Hormonal health
Gastrointestinal symptoms
Kidney and liver function
Medication and supplement use
Other diagnosed medical conditions
She gives the example of a patient with poor sleep, sleep apnea, nutritional problems, and hormonal concerns.
Even when an infection is appropriately diagnosed and treated, those additional medical issues may continue contributing to symptoms.
Her broader message is that patients deserve a comprehensive assessment rather than an assumption that every symptom has one explanation.
Treating a confirmed infection and addressing other health conditions are complementary goals, not competing approaches.
Supportive lifestyle and nutritional care can be important, but they do not replace appropriate antimicrobial treatment for infections that require it.
The Importance of Nutrition, Gut Health, Hormones, and Sleep
Dr. McLaughlin describes laboratory evaluation as an important part of her practice.
Depending on the patient's history and symptoms, she may assess nu
Misdiagnosed With Epilepsy? Lyme Disease, AI & Patient Advocacy – Payton Bradsky | LIVE from ILADS
2026/11/16
What happens when unexplained seizure-like episodes lead to an epilepsy diagnosis, but the tests don't provide clear answers? And could artificial intelligence help Lyme disease patients navigate the medical system with greater confidence?
In this LIVE from ILADS episode of the Tick Boot Camp Podcast, co-host Rich Johannesen interviews Payton Bradsky, Lyme disease survivor, former Google employee, and co-founder of LymeLess Health, an AI-powered platform designed to support people navigating Lyme disease and associated tick-borne illnesses.
Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, this conversation follows Rich's interview with Payton's brother and business partner, Carter Bradsky.
Payton shares her experience with sudden seizure-like episodes during her senior year of college, an epilepsy diagnosis that was eventually withdrawn, and approximately four years of treatment for Lyme disease and coinfections.
She also explains how her family's experiences inspired her and Carter to leave their careers and create LymeLess Health, a technology platform designed around the needs of patients.
At the center of LymeLess is Ella, an AI companion that helps patients organize symptoms, track treatments, receive reminders, maintain health histories, and prepare reports for medical appointments.
Their goal is to give patients the kind of support and organization they wish they had during their own Lyme disease journeys.
Episode 576: Can AI Transform Lyme Disease Care? Carter & Payton Bradsky of LymeLess
From South Dakota to New York City, Google, and LymeLess
Originally from South Dakota, Payton eventually moved to New York City, built a career at Google, and later relocated to North Carolina.
During the interview, Rich congratulates her on her engagement and move.
Payton explains that she spent approximately five years working at Google while navigating her own health challenges.
Her technical background would eventually become central to her next professional chapter.
But before becoming a healthcare technology entrepreneur, Payton experienced firsthand how difficult navigating Lyme disease could be.
Her family's experience began with her mother, who spent years searching for answers to unexplained symptoms.
Her brother Carter subsequently became ill, experiencing debilitating brain fog, memory difficulties, and other symptoms that ended his opportunity to play competitive college basketball.
Then Payton developed symptoms of her own.
Seizure-Like Episodes and an Epilepsy Diagnosis
Payton recalls that her symptoms became especially concerning during her senior year of college.
She began experiencing unexpected seizure-like episodes.
These events led to an epilepsy diagnosis and treatment with anti-seizure medication.
However, Payton describes receiving negative or inconclusive results from the tests and scans performed during her neurological evaluation.
She says her neurologist eventually acknowledged that her symptoms did not clearly resemble epilepsy but was reluctant to withdraw the diagnosis or discontinue medication.
Payton found the uncertainty and medication effects difficult to manage.
Because her mother and brother had already experienced Lyme disease, her family wondered whether a tick-borne illness might be contributing to her symptoms.
She sought evaluation from a naturopathic provider familiar with Lyme disease and reports that she subsequently received a Lyme disease diagnosis.
Her epilepsy diagnosis was eventually withdrawn.
Looking back, Payton recognized additional symptoms, including brain fog and headaches, that she believed were connected to her illness.
Her story illustrates the importance of continuing appropriate medical evaluation when symptoms remain unexplained.
Seizure-like episodes can have many causes, and Lyme disease is not a common explanation. Such symptoms require qualified neurological assessment, and anti-seizure medication should never be stopped without medical supervision.
Four Years of Lyme Disease Treatment
Payton describes spending approximately four years undergoing treatment for Lyme disease and associated infections.
During that time, she graduated from college and began her career.
Her brother Carter was also navigating his recovery, and the siblings supported one another throughout their overlapping health journeys.
They frequently discussed the challenges of managing symptoms, medications, treatment protocols, medical records, and uncertainty.
Even though their family was already familiar with Lyme disease, Payton explains that navigating the illness remained extremely difficult.
She recognized that other patients might face even greater obstacles without a knowledgeable family member or supportive network.
This realization became a major motivation behind LymeLess Health.
Why Payton and Carter Founded LymeLess Health
Payton and Carter began discussing how technology could help address the problems they had encountered.
Both understood the burden of managing complicated treatment plans while experiencing symptoms such as fatigue and cognitive difficulties.
They also recognized how difficult it could be to identify reliable resources and understand changes in symptoms over time.
Payton's experience at Google helped her recognize opportunities involving artificial intelligence, machine learning, and digital health technology.
Eventually, the siblings decided to leave their jobs and pursue their vision.
They founded LymeLess Health, a patient-focused platform designed to make the Lyme disease journey more organized, informed, and manageable.
Payton explains that their goal is to build something that supports patients throughout their everyday experiences—not simply provide another source of general health information.
Meet Ella: The AI Companion for Lyme Disease Patients
At the center of LymeLess is Ella, an artificial intelligence companion designed to help patients manage their health information.
Payton explains that Ella incorporates Lyme-related educational resources and information provided by individual patients.
The platform is designed to bring together several tools that patients might otherwise manage separately.
Symptom Tracking
Patients can record symptoms and monitor how they change over time.
This may help them recognize patterns and communicate more clearly with healthcare providers.
Treatment Tracking and Reminders
LymeLess allows users to record treatments, receive reminders, and maintain a history of their care.
These tools are intended to help patients manage complex routines involving medications, supplements, and other interventions.
Personal Health Records
Patients can organize information about previous treatments, symptoms, and medical experiences.
Having this information in one place may reduce the need to reconstruct health histories from memory.
AI-Powered Insights
Ella helps patients explore their recorded information and identify patterns that may be useful to discuss with their clinicians.
These insights are informational and do not establish diagnoses or treatment effectiveness.
Medical Appointment Reports
One of the features Payton highlights is the ability to generate organized reports for healthcare appointments.
Rather than struggling to remember months of symptoms and treatments during a short visit, patients can bring a structured summary to their provider.
The goal is to help patients become more informed and organized participants in their healthcare.
Ella is not a substitute for a qualified medical professional, and AI-generated information should be reviewed critically.
Turning Patient Experiences Into Research Opportunities
Payton's vision extends beyond helping individuals organize their health information.
She hopes LymeLess can eventually contribute to research by bringing together appropriately collected patient experiences.
People with Lyme disease and associated conditions may experience different symptoms, follow different treatment protocols, and report different outcomes.
Payton believes that technology could help researchers explore these differences and identify patterns worth investigating.
She discusses the possibility of examining patient groups with similar characteristics, including laboratory results, health histories, and treatment experiences.
These insights could potentially inform future research questions.
However, patient-reported experiences cannot independently establish whether a treatment is safe or effective.
Scientific validation, reliable data collection, privacy safeguards, and appropriate study designs are essential before drawing clinical conclusions.
Built With Feedback From Lyme Disease Patients
Payton explains that the LymeLess team interviewed more than 100 patients while developing the platform.
These conversations helped the founders understand the challenges people encounter during diagnosis, treatment, and ongoing care.
She emphasizes that the company wants to continue learning from patients.
Rather than building features based solely on assumptions, Payton wants users to share what is working, what is not, and what would make their daily lives easier.
Her approach reflects the company's origins as a platform created by people with firsthand experience navigating Lyme disease.
The goal is to develop technology around the needs of patients rather than expecting patients to adapt to complicated technology.
The Role of Family and Community Support
Payton repeatedly emphasizes how important her mother's support was during her illness.
Her mother had already navigated a difficult diagnostic journey and was able to help both children recognize potential health concerns and identify resources.
Payton and Carter want LymeLess to provide some of that same organizational and educational support to people who may not have a family member with similar experi
Reaching Recovery: Lyme Disease Healing, Herbs, Nervous System Support & the Long Game
2026/11/14
Read transcript
This episode is a little different from a typical Tick Boot Camp Podcast interview. Matt Sabatello and Rich Johannsen joined Liza from Vital Plan for a live community event titled “Reaching Recovery: What It Takes to Get There and Stay There,” originally presented as part of Vital Plan’s Cellular Healing Bootcamp.
In this candid conversation, Matt shares the story of going from an extremely active long-distance runner to being bedbound with severe neurological symptoms, seizures, cognitive dysfunction, chronic pain, and profound fear about his future. He explains how his recovery unfolded gradually over several years and how community, belief, nervous system support, herbal medicine, movement, lifestyle changes, and learning from hundreds of Tick Boot Camp guests helped him rebuild his life.
Rich shares what it was like to watch Matt’s transformation firsthand and reflects on the patterns he has observed after more than 600 interviews with people navigating Lyme disease, tick-borne illness, chronic illness, and recovery.
A major focus of the discussion is Matt and Rich’s experience with Dr. Bill Rawls’ herbal approach and Vital Plan, including Restore180, HPA Balance, nervous system regulation, gut support, movement, sleep, stress management, and what long-term maintenance can look like after significant recovery.
Matt also tells a deeply personal story he had never publicly shared before: while hospitalized and extremely ill, his mother and grandmother were praying for him when the giant word “HEALED” appeared on the television in his hospital room. At the time, Matt did not believe recovery was possible. Years later, connecting with people through Tick Boot Camp who had regained their health helped him slowly replace fear and doubt with hope.
In This Episode
Matt and Rich discuss:
Matt’s progression from early exercise-induced symptoms to being completely bedbound
Seizures, neurological symptoms, hallucinations, vision problems, chronic pain, and cognitive dysfunction
Matt’s Lyme disease diagnosis and his personal experience with IV antibiotics
Why recovery continued long after his initial antibiotic treatment
The fear of trying new treatments when you are already extremely sick
Starting slowly with herbs and gradually building tolerance
Matt’s experience with Vital Plan’s Restore Kit, now part of Restore180
HPA Balance and the role Matt and Rich say it played in stress regulation and sleep
How fear, hypervigilance, and the nervous system can become part of the chronic illness experience
Why Matt believes community was essential to rebuilding hope
Rich’s perspective on moving gradually from doubt toward belief that recovery is possible
What it means to be “healed” or “recovered” when nobody feels perfect every day
Going from being unable to participate consistently in the podcast to working full time, exercising, traveling, attending events, and living an active life
Matt’s gradual return to walking and eventually running again
The difference between active treatment and long-term maintenance
Matt and Rich’s current approach to herbs and supplements
Diet, sleep, stress management, movement, boundaries, and nervous system support
How Matt handles demanding days without immediately fearing a major relapse
Why setbacks do not necessarily mean starting over
The importance of listening to your body and adjusting over time
Restore180 and Vital Plan’s approach to long-term herbal support
Questions from the live audience about body buzzing, leg pain, sleep, tinnitus, Lyme testing, herbs, and maintenance
Matt’s personal experience with changing autoimmune-related laboratory markers during his recovery
Why Matt and Rich emphasize agency, education, community, and hope
Matt’s Recovery Philosophy
One of the central themes of this conversation is that Matt’s recovery did not happen overnight.
There was no single morning when he woke up and suddenly declared himself healed.
Instead, progress happened gradually.
He began showing up for more Tick Boot Camp interviews. He started walking farther. His cognitive function improved. He returned to a demanding professional career. Eventually, he was able to exercise and run again.
And at some point, Lyme disease was no longer the center of his daily life.
For Matt, that became an important part of what recovery means.
Herbs, Restore180 & Dr. Bill Rawls
Matt and Rich also share their personal experiences with the herbal protocols developed by Dr. Bill Rawls.
Matt describes beginning extremely cautiously because he was afraid of triggering a setback. Rather than rapidly starting a full protocol, he gradually introduced herbs over several months and paid close attention to how his body responded.
The conversation explores the idea that herbal medicine may be approached not only through the lens of targeting microbes, but also through supporting broader aspects of wellness such as stress response, sleep, cellular health, gut health, and immune function.
Learn more about Vital Plan’s Restore180 program:
Explore Restore180 from Vital Plan
Watch the Original Vital Plan Community Event
This conversation was originally recorded live for the Vital Plan community as part of its Cellular Healing Bootcamp.
View the Reaching Recovery event page
More with Dr. Bill Rawls on Tick Boot Camp
Dr. Bill Rawls was one of the earliest guests on the Tick Boot Camp Podcast and has returned for multiple conversations covering Lyme disease, herbal medicine, cellular wellness, chronic illness, immune health, and recovery.
Explore all Tick Boot Camp interviews with Dr. Bill Rawls
A Message for Anyone Still in the Thick of It
One of the strongest themes of this live conversation is that recovery can be gradual, nonlinear, and difficult to recognize while it is happening.
Matt went from being unable to walk to the bathroom safely to working full time, exercising, traveling, attending Lyme community events, producing Tick Boot Camp, and living a life he once could not imagine.
The message from Matt and Rich is simple: keep learning, keep making thoughtful decisions, surround yourself with people who give you hope, and do not let a difficult day convince you that progress is impossible.
Sometimes recovery begins by doubting the possibility of healing just a little bit less.
Learn more about Lyme disease, recovery stories, doctors, researchers, and hundreds of patient journeys at Tick Boot Camp.
Lyme Disease Ended His Basketball Dreams. Now He's Helping Patients With AI – Carter Bradsky | LIVE from ILADS
2026/11/14
He was preparing to play college basketball when Lyme disease changed everything. Now he's using artificial intelligence to help other patients navigate the journey he wishes he never had to face alone.
In this LIVE from ILADS episode of the Tick Boot Camp Podcast, co-host Rich Johannesen sits down with Carter Bradsky, Lyme disease survivor and co-founder of LymeLess Health, to discuss how a devastating family experience with Lyme disease, Bartonella, and Babesia inspired an innovative patient-built healthcare platform.
Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, this conversation explores the challenges of living with chronic illness as a young adult, losing athletic opportunities, navigating college with debilitating brain fog, and struggling to find reliable information and community support.
Carter shares how his mother's prolonged search for a Lyme disease diagnosis helped his family recognize his own symptoms and connect with a healthcare provider.
After approximately two and a half years of treatment and recovery, Carter and his sister, Payton Bradsky, decided to build something they wish had existed during their own illnesses.
The result is LymeLess Health, an AI-powered care management platform designed specifically for people navigating Lyme disease and associated tick-borne infections.
Their mission is to make the Lyme disease journey less isolating, less confusing, and more manageable by bringing together patient experiences, health information, educational resources, and technology.
What if patients didn't have to spend years searching for the information, support, and guidance that others have already discovered through their own experiences?
That's the question driving Carter and Payton's work.
Episode 576: Can AI Transform Lyme Disease Care? Carter & Payton Bradsky of LymeLess
A Family's Journey Through Lyme Disease
Carter explains that his family's experience with Lyme disease began approximately a decade before this interview.
His mother developed debilitating symptoms while living in Arizona and spent years searching for an explanation.
According to Carter, she underwent more than 100 medical tests and encountered multiple physicians before receiving a diagnosis.
During that time, she experienced medical dismissal and was told that her symptoms might be psychological.
At one point, multiple sclerosis was considered as a possible explanation.
A chance conversation with the mother of one of Carter's high school friends—who was a naturopathic provider familiar with Lyme disease—encouraged the family to investigate tick-borne illness.
That encounter eventually helped his mother connect with a physician who diagnosed and treated her.
Carter emphasizes how much luck played a role in his mother's journey.
Without that unexpected connection, he wonders how much longer she might have continued searching for answers.
Her experience would later become critically important when Carter developed symptoms of his own.
From Competitive Basketball to Debilitating Brain Fog
As a high school senior in South Dakota, Carter was preparing for an exciting transition.
He was graduating, heading to college, and had an opportunity to play competitive basketball at the university level.
Basketball had been an important part of his identity.
Then his health began to deteriorate.
Carter describes developing symptoms that included:
Severe brain fog
Memory loss
Dissociation
Anxiety
Difficulty concentrating
Cognitive challenges affecting academic performance
Fear and physical discomfort associated with athletic activity
He remembers going from feeling confident and engaged on the basketball court to experiencing anxiety about returning to play.
The sport that had once brought him tremendous happiness became something he could no longer participate in.
Because his mother had already experienced Lyme disease, she recognized similarities in his symptoms and encouraged him to seek evaluation.
They traveled to Northern California to see the physician who had helped her.
Carter reports that Bartonella and Babesia were identified as significant components of his illness.
He describes undergoing approximately two and a half years of treatment involving antibiotics, herbal support, and other interventions before regaining his health.
His treatment experience is personal testimony, not evidence that the same regimen is appropriate or effective for every patient.
Losing the College Experience to Chronic Illness
One of the most emotional parts of the conversation centers on what Lyme disease took away from Carter during college.
He explains that he had to abandon competitive athletics.
But the loss extended far beyond basketball.
While classmates were enjoying college life, making friends, attending social events, and pursuing academic goals, Carter was struggling simply to get through the day.
He recalls attending philosophy classes and being unable to remember assigned reading.
When professors called on him, he sometimes struggled to answer questions because of his cognitive symptoms.
He describes feeling embarrassed, isolated, and disconnected from the experiences his peers were having.
Instead of enjoying a typical college social life, Carter focused on three priorities:
Getting through class, spending time at church, and sleeping.
His academic goal shifted from excelling to simply being able to complete his coursework.
For a young adult who had previously been active, confident, and competitive, the experience was deeply challenging.
Carter explains that he did not know where to find Lyme disease support groups, educational resources, or organizations such as ILADS.
He felt as though he were navigating an overwhelming illness without a community that understood what he was experiencing.
That isolation eventually became one of the primary problems he wanted LymeLess to address.
The Hidden Burden of Managing Lyme Disease Treatment
Carter also discusses the practical challenges of managing complex treatment plans while attending college.
He remembers trying to organize numerous medications and supplements while keeping his illness private.
For patients managing multiple prescriptions, supplements, appointments, and changing symptoms, the organizational burden can become substantial.
Carter describes the experience of having a kitchen counter filled with bottles and trying to remember what to take and when.
At the same time, he was struggling with brain fog and memory difficulties.
The very symptoms he was experiencing made managing his care more difficult.
He also recalls uncertainty about whether his treatments were helping and whether he was making the right decisions.
Questions frequently occupied his thoughts:
Am I receiving the right care?
Are these treatments helping?
What should I do next?
Are other patients experiencing similar symptoms?
Where can I find reliable information?
Will I ever get better?
These challenges helped shape his vision for a technology platform that could support patients with organization, education, and care navigation.
Meet LymeLess Health: Built by Patients, for Patients
After Carter and Payton experienced their own Lyme disease journeys, they began discussing how technology could help address problems they had encountered.
They founded LymeLess Health, a patient-centered platform focused on Lyme disease and associated tick-borne infections, which the company collectively refers to as Lyme+.
Their goal is to help patients manage the complexity of chronic illness by bringing important information into one place.
During the interview, Carter describes the platform as a personalized AI companion informed by Lyme-related educational resources, individual health information, and insights from the patient community.
Rather than requiring patients to search across multiple websites, social media groups, medical records, and personal notes, LymeLess aims to make relevant information easier to organize and access.
The company's philosophy is rooted in a simple idea:
Patients should not have to rely on luck to find helpful information and support.
Carter and Payton want to use technology to make the experiences and knowledge accumulated throughout the Lyme disease community more accessible to others.
Learn more about LymeLess Health and its mission.
Meet Ella: An AI Companion for Lyme Disease Patients
At the center of LymeLess is Ella, an AI-powered companion designed to help people navigate Lyme disease and complex treatment journeys.
Carter describes the concept as creating a digital resource that could provide some of the organizational and informational support his mother offered him during his illness.
The platform is designed to help patients better understand their own health experiences while preparing for conversations with healthcare professionals.
LymeLess describes capabilities involving:
Symptom and Treatment Tracking
Patients can record symptoms, treatments, and changes in how they feel over time.
Tracking this information may help individuals identify patterns worth discussing with their healthcare providers.
Organizing Medical Information
The platform is designed to bring medical history, treatment details, and other health information into a more accessible format.
This may be particularly useful for patients who struggle with brain fog, memory difficulties, or extensive medical records.
Educational Support
Ella provides access to Lyme-related information and resources intended to help patients become more informed about their conditions.
Preparing for Medical Appointments
By organizing symptoms, treatment histories, and questions, patients may be better prepared to communicate with their healthcare professionals.
Learning From Community Experiences
LymeLess aims to use aggregated patient experiences to help identify patterns and provide ad
Can Ozempic Help MCAS and Chronic Lyme? Dr. Tania Dempsey's New Research | LIVE from ILADS
2026/11/13
Could medications best known for weight loss and diabetes offer a new way to manage mast cell activation syndrome (MCAS), inflammation, and symptoms experienced by some patients with chronic Lyme disease?
In this LIVE from ILADS episode of the Tick Boot Camp Podcast, co-host Rich Johannesen reunites with Dr. Tania Dempsey, MD, a physician specializing in complex chronic illness, mast cell activation syndrome, and tick-borne diseases, for an exciting discussion about emerging research into GLP-1 medications and immune system dysfunction.
Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation centers on Dr. Dempsey's recently published research investigating GLP-1 receptor agonists—medications such as Ozempic, Wegovy, Mounjaro, and Zepbound—as potential treatments for patients with MCAS.
Dr. Dempsey discusses a 47-patient case series in which 87% of participants reportedly experienced a positive response to GLP-1-based treatment. She explains why these medications may have effects beyond blood sugar regulation and weight management, including potential influences on mast cell activity and inflammation.
The interview also explores how mast cell dysfunction may interact with other components of the immune system, why Dr. Dempsey questions relying exclusively on antibody testing when evaluating certain complex patients, and how emerging molecular diagnostic methods could influence the future of tick-borne disease care.
Throughout the conversation, Dr. Dempsey emphasizes the importance of individualized treatment, continuing research, and helping both patients and healthcare professionals better understand complicated chronic illnesses.
Could GLP-1 medications represent a new direction in MCAS research? And what might that mean for patients living with Lyme disease, Bartonella, and overlapping inflammatory symptoms?
This episode explores those questions while distinguishing promising early clinical observations from treatments that have been conclusively established through larger controlled studies.
Meet Dr. Tania Dempsey, MD: MCAS and Complex Chronic Illness
Dr. Tania Dempsey is a physician known for her clinical work with patients experiencing mast cell activation syndrome, Lyme disease, tick-borne infections, and other complex chronic conditions.
Her interests include the relationship between immune system dysfunction, inflammation, environmental exposures, and persistent symptoms.
Dr. Dempsey has become an increasingly prominent voice in discussions about MCAS and its potential relationship with other chronic illnesses.
During this interview, she shares how appearing on major podcasts, including Dave Asprey's podcast, has helped her reach a broader audience.
She explains that although she loves working directly with patients, her larger mission is to share information with healthcare professionals and patients around the world.
Dr. Dempsey also discusses her involvement with the International Lyme and Associated Diseases Society (ILADS).
At the time of this interview, she had served on the ILADS Board of Directors for two years and had recently been reelected for another two-year term.
She describes physician education, research, and public awareness as important priorities for her continued work with the organization.
For an in-depth discussion of her clinical interests, listen to her previous Tick Boot Camp appearance: Dr. Tania Dempsey on MCAS, Chronic Lyme Disease, GLP-1 Agonists, Biofilms, and Precision Medicine.
New Research: GLP-1 Medications for Mast Cell Activation Syndrome
One of the biggest developments Dr. Dempsey shares is her recently published research on GLP-1 receptor agonists and MCAS.
GLP-1 receptor agonists are medications primarily used for conditions such as type 2 diabetes and obesity.
Some of the medications discussed include:
Ozempic: Semaglutide
Wegovy: Semaglutide
Mounjaro: Tirzepatide
Zepbound: Tirzepatide
Semaglutide acts on GLP-1 receptors, while tirzepatide acts on both GLP-1 and GIP receptors.
Although these medications are widely associated with weight management, researchers are also investigating their broader metabolic and inflammatory effects.
Dr. Dempsey explains that her research explores whether these effects could benefit certain patients with mast cell activation syndrome.
She presented findings from the research at the ILADS conference and describes receiving enthusiastic feedback from other clinicians interested in the potential applications.
Importantly, GLP-1 medications are not established or FDA-approved treatments for MCAS. The findings discussed in this episode are preliminary and require further research to determine effectiveness, safety, appropriate patient selection, and dosing.
The 47-Patient GLP-1 and MCAS Case Series
Dr. Dempsey highlights findings from a published case series involving 47 patients.
According to her description:
The case series included 47 patients receiving GLP-1-based treatment.
Approximately 87% reportedly experienced a significant positive response.
Some patients reported improvements in joint pain.
Others experienced reductions in brain fog and additional symptoms.
Certain patients reported noticeable changes within hours of treatment.
Treatment approaches were individualized, including the use of low doses in some patients.
These observations have generated interest because MCAS can be challenging to manage, particularly in patients who report sensitivities to multiple medications or supplements.
Dr. Dempsey describes the results as especially encouraging for patients whose symptoms have persisted despite other interventions.
However, a case series does not establish that a medication caused the reported improvements.
Without a randomized control group, it is difficult to distinguish treatment effects from other influences, including natural symptom fluctuations, concurrent treatments, and selection bias.
The reported 87% response rate should therefore be understood as a finding from this particular patient group—not a predicted success rate for everyone with MCAS.
Larger, well-controlled clinical studies are needed.
What Is Mast Cell Activation Syndrome (MCAS)?
Rich asks Dr. Dempsey to explain MCAS in terms that patients without medical training can understand.
She begins by describing the normal function of mast cells.
Mast cells are immune cells that help the body respond to infections, allergens, and other potential threats.
When activated, they release substances called mediators, which participate in immune signaling and inflammation.
These mediators include histamine, cytokines, and other biologically active compounds.
Under normal circumstances, mast cell activation is part of the body's protective response.
Dr. Dempsey explains that in people with MCAS, mast cells may activate inappropriately or release mediators in ways that produce recurring symptoms.
Because mast cells are present throughout the body, abnormal activation can affect multiple organ systems.
MCAS is a recognized clinical condition, but diagnosing it requires more than the presence of nonspecific symptoms. Accepted diagnostic approaches consider characteristic episodes affecting multiple organ systems, objective evidence of mast cell mediator release, and response to appropriate treatment.
Is MCAS an Overactive or Underactive Immune System?
Rich asks whether MCAS should be understood as an overactive immune system, an underactive immune system, or an autoimmune disorder.
Dr. Dempsey explains that she views the problem as potentially involving both excessive activation and impaired regulation.
She describes how mast cells communicate with other immune cells through chemical signals.
In her explanation, persistent mast cell activation may contribute to inflammatory activity while also influencing how other components of the immune system respond.
She suggests that some patients may experience excessive inflammatory signaling alongside less effective immune responses in other areas.
This proposed interaction is particularly important to her approach to patients with complex chronic illness.
However, MCAS is not universally defined as a combination of overactive and suppressed immunity, and the specific mechanisms connecting mast cell activation with persistent tick-borne infections remain under investigation.
Dr. Dempsey's explanation reflects her clinical interpretation of a complicated and evolving area of immunology.
MCAS, Lyme Disease, Bartonella, and Chronic Inflammation
Dr. Dempsey discusses how mast cell activation may intersect with conditions such as Lyme disease, Bartonella infection, and environmental exposures.
She explains that her clinical approach considers both potential triggers and the patient's immune response.
For example, she may evaluate suspected infections or environmental concerns while also addressing symptoms she attributes to mast cell activation.
Her goal is to reduce inflammatory symptoms while investigating other possible contributors to illness.
Dr. Dempsey emphasizes that patients with complex chronic conditions may have multiple overlapping problems that require different approaches.
The relationship between MCAS and persistent symptoms attributed to Lyme disease or Bartonella is an active area of clinical interest, but it has not been established that MCAS is the underlying cause of persistent symptoms in most such patients.
Patients with chronic symptoms benefit from a comprehensive evaluation that considers confirmed infections, other medical conditions, medication effects, and additional potential explanations.
Can Mast Cell Dysfunction Affect Lyme Disease Antibody Testing?
One of the interview's most thought-provoking discussions concerns the interpretation of antibody tests.
Rich asks whether immune dysfunction could affect the reliability of laboratory tests that depend on de
Why Lyme Patients Feel Dismissed: How to Get Doctors to Listen – Dr. Kirsten FitzGerald | LIVE from ILADS
2026/11/12
What do you do when you're sick, your Lyme disease test comes back negative, and your doctor tells you everything is fine—even though you know something is wrong?
For many people living with Lyme disease, tick-borne infections, and complex chronic illness, the search for answers can involve years of unexplained symptoms, multiple specialists, frustrating medical appointments, and feeling dismissed by the healthcare system.
But what if improving the patient-doctor relationship could become one of the most important steps toward finding answers?
In this LIVE from ILADS episode of the Tick Boot Camp Podcast, co-host Rich Johannesen sits down with Dr. Kirsten P. FitzGerald, DNP, FNP-BC, a board-certified family nurse practitioner and functional medicine provider based in Ridgefield, Connecticut, to discuss Lyme disease awareness, missed diagnoses, patient advocacy, and the importance of building collaborative relationships between patients and healthcare professionals.
Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, this conversation explores how Dr. FitzGerald transitioned from conventional primary care into functional and integrative medicine after recognizing that some patients with persistent symptoms were not finding the answers or support they needed.
Dr. FitzGerald shares her experiences working with patients affected by Lyme disease, long COVID, mast cell-related concerns, and pediatric neuroinflammatory conditions, including PANS and PANDAS.
Together, Rich and Dr. FitzGerald develop a practical framework for helping patients prepare for medical appointments, communicate more effectively, participate in treatment decisions, and work with their providers toward better health outcomes.
Their central message: Patients deserve to be heard, and meaningful progress often begins when patients and clinicians work together as partners.
Meet Dr. Kirsten P. FitzGerald, DNP, FNP-BC
Dr. Kirsten P. FitzGerald is a Doctor of Nursing Practice and board-certified Family Nurse Practitioner with more than 25 years of healthcare experience.
She is the founder of FitzGerald Health and Wellness, an integrative and functional medicine practice in Ridgefield, Connecticut.
She also collaborates with the team at New Frontiers Functional Medicine & Nutrition, led by Dr. Kara Fitzgerald in Sandy Hook, Connecticut, and works alongside pediatric naturopathic physician Dr. Lindsey Wells, ND, in Trumbull, Connecticut.
Her clinical interests include:
Lyme disease and tick-borne infections
Persistent and complex chronic symptoms
Long COVID and post-infectious illness
Functional and integrative medicine
Mast cell activation syndrome (MCAS)
PANS and PANDAS
Metabolic health and lifestyle medicine
Patient education and collaborative care
Dr. FitzGerald grew up on a trout farm in Connecticut and has spent much of her life around animals, including horses, chickens, cats, and dogs.
Despite living in a region historically associated with Lyme disease, she explains that her understanding of the complexity of tick-borne illness changed significantly after attending a professional presentation.
That experience ultimately helped redirect her medical career.
Learn more about Dr. Kirsten FitzGerald and her clinical background.
From Conventional Primary Care to Functional Medicine
Dr. FitzGerald describes a pivotal moment at an advanced practice registered nurse (APRN) conference in Connecticut.
A presentation by fellow clinician Pam Cipriano challenged her understanding of Lyme disease and prompted her to reconsider patients she had previously encountered.
She began thinking about people whose Lyme disease test results had been negative despite symptoms and exposure histories that continued to raise clinical questions.
Dr. FitzGerald explains that conventional primary care often relies on established diagnostic pathways, laboratory testing, and specialist referrals.
These tools are essential, but she became increasingly concerned about patients whose symptoms remained unexplained after multiple evaluations.
During the COVID-19 pandemic, she encountered additional patients struggling with persistent symptoms, including long COVID.
One experience was particularly influential.
A patient who was also a nurse became emotional during an appointment and asked Dr. FitzGerald to stop sending her to additional specialists.
The patient wanted someone to take responsibility for understanding her overall health picture rather than continuing a cycle of referrals without satisfactory answers.
For Dr. FitzGerald, that conversation reinforced the need to expand her knowledge and explore different approaches to complex chronic illness.
She eventually transitioned toward functional and integrative medicine, including working with Dr. Kara Fitzgerald's New Frontiers team.
The conversation illustrates why continuity of care, clinical curiosity, and thoughtful follow-up matter when patients experience symptoms that do not fit neatly into one diagnosis.
Why Lyme Disease Can Be Difficult to Recognize
Dr. FitzGerald expresses frustration that Lyme disease and other tick-borne illnesses are not always considered during evaluations of patients with unexplained symptoms—even in Connecticut.
She describes how patients may visit several specialists for seemingly unrelated problems without anyone initially recognizing a possible connection.
Symptoms discussed include:
Persistent fatigue
Brain fog and cognitive difficulties
Headaches and migraines
Tremors and neurological complaints
Joint and muscle pain
Changes in mood or irritability
Symptoms initially attributed to aging or menopause
Other unexplained changes in physical functioning
Dr. FitzGerald explains that patients may see orthopedic specialists for pain, neurological specialists for tremors, and other providers for fatigue or cognitive concerns.
Each specialist may focus on a particular symptom or organ system.
Her concern is that clinicians can sometimes miss the broader pattern.
Could several seemingly unrelated symptoms have a common explanation?
Lyme disease and other tick-borne infections are among the conditions that may warrant consideration when a patient's history and clinical findings support that possibility.
However, these symptoms are not specific to Lyme disease. Many other medical conditions can produce similar complaints, and appropriate evaluation should consider alternative explanations.
Dr. FitzGerald's message is not simply to test everyone for Lyme disease, but to remain attentive to exposure history, symptom patterns, and unresolved clinical questions.
For more information about the strengths and limitations of available tests, explore Tick Boot Camp's Lyme Disease Testing Resource.
When Lyme Disease Tests Are Negative but Symptoms Continue
One of the challenges discussed in the episode is the interpretation of Lyme disease testing.
Dr. FitzGerald recalls patients whose initial tests were negative even though she remained concerned about the possibility of tick-borne illness.
Rich and Dr. FitzGerald discuss the frustration patients can experience when a negative test result ends the conversation despite ongoing symptoms.
Lyme disease testing has important limitations, particularly early in infection, when antibodies may not yet be detectable.
At the same time, persistent symptoms and negative testing do not automatically establish an undiagnosed Lyme infection.
The appropriate next step depends on the patient's symptoms, exposure history, examination, timing of testing, and other potential diagnoses.
This episode encourages patients to ask informed questions about test results rather than assuming that one result always tells the complete story.
Why Dr. FitzGerald Attends ILADS Conferences
Dr. FitzGerald explains that attending the ILADS conference helps her expand her understanding of tick-borne illnesses and connect with healthcare professionals who encounter complex cases.
She values opportunities to learn from other clinicians, explore research, and discuss diagnostic challenges.
She also hopes to bring information back to her colleagues in conventional medical settings.
Throughout the interview, Dr. FitzGerald emphasizes that changing medical practice requires education, open dialogue, and a willingness to consider new evidence.
She believes that increasing awareness among primary care providers, nurse practitioners, pediatricians, and other healthcare professionals can help patients receive more informed evaluations.
The conference also provides an opportunity to connect with clinicians who share her interest in patient-centered care.
The Patient-Doctor Relationship: A Partnership, Not a One-Way Conversation
The conversation takes an important turn when Rich asks Dr. FitzGerald a question that patients do not always hear:
What can patients do to help their doctors provide better care?
Rather than focusing exclusively on the shortcomings of the healthcare system, Rich suggests that patients may benefit from approaching medical appointments as active participants.
Dr. FitzGerald agrees.
She explains that patients can contribute valuable information that may not be immediately apparent from laboratory results or a brief office visit.
Together, they discuss how a collaborative relationship allows both the patient and clinician to make better use of their time, knowledge, and resources.
This does not mean patients are responsible for diagnostic errors, inadequate access to care, or dismissive treatment.
Instead, the conversation offers practical ways for patients to strengthen communication and advocate for themselves within the healthcare system.
Step 1: Prepare Thoroughly Before Your Medical Appointment
Dr. FitzGerald explains that her initial consultations typically last at least two hours and sometimes extend to three hours.
Before those appointments, she asks
Why Treating Lyme Disease Requires More Than Antibiotics – Dr. Sigrid Blehle | LIVE from ILADS
2026/11/11
What happens when Lyme disease treatment focuses on infections, but patients continue struggling with debilitating symptoms? Could mold exposure, gut health, immune dysfunction, or other underlying health challenges be complicating recovery?
In this LIVE from ILADS interview, Tick Boot Camp co-host Rich Johannesen welcomes Dr. Sigrid Blehle, MD, MBA, PhD, Medical Director of Alviasana in Augsburg, Germany, to explore her integrative approach to Lyme disease, chronic infections, and complex chronic illness.
Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, this conversation examines why Dr. Blehle believes that identifying and treating infections is only one part of helping patients with complicated medical histories.
Dr. Blehle discusses her approach to evaluating environmental exposures, mold, heavy metals, gut microbiome health, immune function, nutritional status, and possible tick-borne infections before developing individualized treatment plans.
She also shares her experience with antibiotic therapy, herbal medicine, intravenous treatments, and other integrative interventions, while explaining how her multidisciplinary clinic works with patients from Europe, the United States, Africa, and Asia.
One of her most striking examples involves a patient who had already consulted 48 physicians before arriving at her clinic.
The central message of this interview is that patients with complex symptoms deserve careful listening, comprehensive medical histories, and individualized evaluation rather than assumptions about what is causing their illness.
Meet Dr. Sigrid Blehle: Lyme Disease Physician in Germany
Dr. Sigrid Blehle, MD, MBA, PhD, is a German physician and Medical Director of Alviasana, an integrative medical clinic based in Augsburg, Germany.
Her clinical interests include:
Lyme disease and other tick-borne infections
Complex and persistent symptoms following infectious illnesses
Post-COVID conditions
Environmental exposures, including mold
Heavy metal exposure
Mast cell activation syndrome (MCAS)
Gut microbiome health
Nutritional and metabolic concerns
Genetic and immune-related factors
Dr. Blehle describes her clinic's approach as comprehensive, emphasizing that patients frequently arrive with overlapping health concerns rather than a single clearly identified diagnosis.
She explains that many of her patients have already visited numerous physicians, undergone extensive testing, and tried multiple treatments before seeking care at Alviasana.
For these patients, her goal is to investigate potentially relevant contributors to their symptoms and develop a personalized treatment strategy.
When You're the 49th Doctor: The Challenges of Complex Chronic Illness
Early in the conversation, Dr. Blehle shares the story of a patient who had already seen 48 doctors before visiting her clinic.
Dr. Blehle became the patient's 49th physician.
The example illustrates a familiar experience for many people living with persistent, unexplained symptoms: years of medical appointments, conflicting explanations, unsuccessful treatments, and uncertainty about what to do next.
Dr. Blehle believes that patients with complex chronic illness often require a broader assessment of their health history.
Rather than assuming that every symptom has the same cause, she considers possible infections alongside environmental, nutritional, immune, and other medical factors.
Rich and Dr. Blehle discuss why listening carefully to the patient's experiences is an essential first step.
For people who have struggled to find answers, a comprehensive evaluation can provide an opportunity to revisit overlooked questions and identify areas that may warrant additional investigation.
Why Dr. Blehle Believes Lyme Disease Treatment Requires a Broader Approach
One of the interview's central themes is Dr. Blehle's belief that treating suspected infections alone may not address every factor contributing to a patient's illness.
She explains that her clinical approach considers the broader health picture, including possible environmental exposures and underlying medical conditions.
For example, a patient may have a history of tick exposure while also experiencing gastrointestinal problems, nutritional deficiencies, or symptoms associated with another illness.
Dr. Blehle believes these issues should be considered together when developing a treatment plan.
Her approach reflects her clinical experience and treatment philosophy. The interview does not establish that all the factors discussed cause persistent Lyme disease symptoms or that treating them improves outcomes for every patient.
Step One: A Comprehensive Patient History
Before ordering laboratory tests, Dr. Blehle begins with an extensive medical history.
She wants to understand not only the patient's symptoms, but also their environment, travel history, previous illnesses, and treatment experiences.
Questions may include:
Where does the patient live?
Have they experienced known or suspected tick bites?
Have they been exposed to mosquitoes or other biting insects?
Have they traveled internationally?
Did symptoms begin after an infection or travel?
Have they lived or worked in buildings with water damage or visible mold?
Have they received antibiotics or other treatments?
What medical diagnoses have previously been considered?
Which symptoms have persisted or changed over time?
Dr. Blehle describes how travel history can provide important clues.
For example, a patient may have become ill during or after traveling abroad, with symptoms continuing long after returning home.
She believes that understanding the timing and circumstances of symptom onset helps determine which diagnostic tests may be appropriate.
Her guiding principle is to use the medical history to select targeted investigations rather than ordering the same extensive laboratory panel for every patient.
Mold Exposure and Environmental Factors in Chronic Illness
Rich asks Dr. Blehle about the relationship between environmental exposures and chronic symptoms.
In particular, they discuss mold exposure in homes and workplaces.
Dr. Blehle explains that she asks patients about their living environments and considers possible mold exposure during the initial assessment.
When environmental concerns arise, she may recommend investigating the home for moisture damage or visible mold, including areas behind wallpaper or walls.
She also discusses using laboratory testing in her clinical evaluation.
Rich emphasizes the importance of identifying and reducing ongoing environmental exposures rather than focusing exclusively on testing the patient.
Does Mold Exposure Affect Lyme Disease Treatment?
Dr. Blehle shares her clinical belief that addressing suspected mold-related problems before antimicrobial treatment may improve the effectiveness of her broader treatment plan.
She describes using a similar sequence when she suspects heavy metal-related concerns.
These are her reported clinical practices, not established evidence that mold or heavy metal treatment improves Lyme disease outcomes.
Mold exposure can contribute to recognized health problems, particularly respiratory symptoms and allergic conditions. However, testing for mold-related illness is complex, and some commercially marketed body tests have not been validated for diagnosing illness caused by indoor mold.
The conversation raises important questions about environmental health while highlighting the need for appropriate medical assessment and evidence-based testing.
Heavy Metals, Genetic Factors, and Metabolic Health
In addition to mold, Dr. Blehle discusses investigating potential heavy metal exposures and selected genetic or metabolic concerns.
She explains that testing depends on the patient's history and clinical presentation.
Her approach includes considering whether certain medical conditions or exposures may be contributing to symptoms.
Rich asks whether she evaluates the body's ability to process or eliminate substances.
Dr. Blehle describes using genetic testing in selected circumstances rather than routinely ordering it for everyone.
This portion of the interview highlights the importance of distinguishing between documented toxic exposures, established medical conditions, and unproven explanations for chronic symptoms.
Heavy metal testing and treatment should be guided by clinically meaningful exposure histories and validated methods.
Gut Microbiome Health and Lyme Disease
One of the most detailed sections of the interview focuses on the gut microbiome, the community of microorganisms living in the digestive tract.
Dr. Blehle explains that many of her patients have previously undergone antibiotic treatment.
Because antibiotics can affect intestinal bacteria, she considers gastrointestinal health when planning additional treatment.
She believes the gut microbiome is an important part of evaluating patients with complex chronic illness.
Research has established connections between the intestinal microbiome and immune function, although the clinical significance of many commercial microbiome test results remains uncertain.
How Does Dr. Blehle Test the Gut Microbiome?
Dr. Blehle describes using stool testing to evaluate aspects of intestinal microbial composition.
She also discusses measuring substances such as histamine in stool samples.
She explains that she may address identified gastrointestinal concerns before beginning additional antimicrobial treatment.
Her goal is to consider digestive health and previous treatment effects as part of the overall care plan.
However, there is currently no universally accepted stool microbiome profile that defines optimal immune health or reliably predicts Lyme disease treatment outcomes.
The interview presents Dr. Blehle's clinical approach rather than establishing that routine microbiome testing is necessary for Lyme disease
25 Doctors, 10 Misdiagnoses: From Lyme Patient to Advocate – Melinda Elliott Sander | LIVE from ILADS
2026/11/10
After seeing 25 doctors, receiving 10 misdiagnoses, and facing the possibility of ALS, multiple sclerosis, or early-onset Alzheimer's disease, Melinda Elliott Sander finally discovered that tick-borne illness was behind her devastating health journey. Today, she's helping change the future of Lyme disease advocacy across America.
In this LIVE from ILADS interview, Tick Boot Camp co-host Rich Johannesen welcomes Melinda Elliott Sander, a Missouri Lyme disease patient advocate and Community Engagement Fellow with Center for Lyme Action, to discuss her journey from seriously ill mother of three to national advocate fighting for improved Lyme disease research, awareness, funding, and patient protections.
Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, this conversation explores the challenges of diagnosing tick-borne diseases in the Midwest, the growing impact of alpha-gal syndrome, and how grassroots advocacy is influencing federal legislation.
Melinda shares how she began contacting lawmakers while bedridden, eventually becoming involved in a national movement that grew from approximately 30–40 early advocates to more than 10,000 participants at the time of the interview.
Rich and Melinda also discuss five federal legislative proposals designed to improve tick-borne disease research, prevention, public health infrastructure, patient protections, and access to information.
Their message is empowering: You don't have to be healthy, wealthy, or politically connected to make a difference. Even when chronic illness has taken so much from you, your voice can help create meaningful change.
Meet Melinda Elliott Sander: Lyme Disease Patient Advocate
Melinda Elliott Sander is a Lyme disease patient advocate from north-central Missouri who has spent approximately a decade raising awareness about Lyme disease and other tick-borne illnesses.
She serves as a Community Engagement Fellow with Center for Lyme Action, a national advocacy organization dedicated to increasing federal funding and advancing policy solutions for Lyme disease, alpha-gal syndrome, and other tick-borne conditions.
Melinda has participated in Center for Lyme Action's advocacy efforts since the organization's early days in 2020.
She now works to strengthen state-level advocacy teams, connect patients with opportunities to participate in public policy, and help expand the organization's national network.
At the time of the interview, Melinda was completing a public health degree at Western Governors University.
Her mission is deeply personal.
After experiencing years of debilitating illness and struggling to obtain an accurate diagnosis, she committed herself to helping other patients avoid the same challenges.
25 Doctors, 10 Misdiagnoses, and Eight Medical Specialties
Approximately 10 years before this interview, Melinda became seriously ill while raising three young children.
Her symptoms were severe, but physicians struggled to determine what was causing them.
During her diagnostic journey, she consulted:
25 physicians
Eight medical specialties
10 different diagnoses
Doctors considered serious neurological conditions, including ALS, multiple sclerosis, and early-onset Alzheimer's disease.
Melinda describes how frightening this experience was, especially while caring for her children and trying to maintain hope for her future.
Eventually, she learned that tick-borne illness was involved.
The diagnosis surprised her.
She had already considered and ruled out numerous possibilities, and tick-borne disease was not something she initially believed could explain her symptoms.
Her experience illustrates the emotional and physical toll of a prolonged diagnostic journey.
It also highlights the importance of comprehensive medical evaluation when patients experience persistent, unexplained symptoms.
Why Lyme Disease Awareness Matters in Missouri
Melinda lives approximately 30 miles north of Columbia, Missouri.
She explains that people in her region are sometimes told Lyme disease does not exist in their state.
Yet Missouri has extensive outdoor activity involving farming, hunting, hiking, and recreation.
Residents regularly encounter ticks in fields, forests, backyards, and other everyday environments.
Melinda believes greater awareness of tick-borne diseases is needed among healthcare professionals and the public.
Rich contrasts her experience with living on Long Island, New York, where Lyme disease is widely recognized.
He explains that patients in highly endemic areas may face different diagnostic challenges than patients in regions where Lyme disease is considered less common.
Importantly, tick-borne disease risks vary by geography and tick species. Missouri is associated with several significant tick-borne health concerns, including ehrlichiosis, spotted fever group rickettsioses, and alpha-gal syndrome.
Melinda's message is that tick exposure should not be dismissed simply because someone lives outside a traditionally recognized Lyme disease hotspot.
For guidance following a tick bite, explore Tick Boot Camp's Tick Bite Blueprint.
Alpha-Gal Syndrome: A Major Public Health Concern in Missouri
One of the most important topics in this interview is alpha-gal syndrome (AGS), a potentially serious allergy associated with certain tick bites.
In the United States, alpha-gal syndrome is strongly associated with bites from the lone star tick.
The condition involves an immune response to alpha-gal, a sugar found in most non-primate mammals.
People with alpha-gal syndrome may experience allergic reactions after consuming certain mammalian foods or encountering other products containing alpha-gal.
Symptoms can include:
Hives and itching
Gastrointestinal distress
Swelling
Breathing difficulties
Severe allergic reactions, including anaphylaxis
Melinda describes Missouri as a significant area of concern for alpha-gal syndrome.
She discusses how the condition can affect farmers, hunters, and families whose livelihoods involve livestock.
Some people may experience serious lifestyle changes as they learn to navigate food ingredients, medications, and other potential exposures.
Melinda's Personal Experience With Alpha-Gal
Melinda reveals that she also developed alpha-gal syndrome.
After years of dealing with Lyme disease and other tick-borne illnesses, she noticed alpha-gal-related symptoms following a COVID-19 infection.
She discusses her physician's hypothesis that changes in immune function may have contributed to the timing of her symptoms.
However, the interview does not establish that COVID-19 caused her alpha-gal syndrome.
Her experience reinforces the importance of further research into tick-associated allergies and immune responses.
Why the Lone Star Tick Is an Important Public Health Concern
Rich and Melinda discuss the aggressive behavior of lone star ticks.
Unlike some tick species that primarily wait on vegetation for a host, lone star ticks can actively move toward potential hosts.
Rich recalls observing this behavior firsthand after removing a lone star tick from his body.
He describes placing the tick on his bathroom sink and watching it repeatedly move toward him.
The conversation highlights why tick prevention matters even during ordinary outdoor activities.
Lone star ticks are associated with several health concerns, including ehrlichiosis and alpha-gal syndrome.
Their expanding geographic distribution has increased attention to prevention, surveillance, and public education.
From Bedridden Lyme Patient to Congressional Advocate
One of the most inspiring parts of Melinda's story is how she began advocating while severely ill.
She recalls lying in bed and writing letters to elected officials.
Even when she lacked the energy to travel or participate in traditional advocacy activities, she found ways to make her voice heard.
She contacted senators, representatives, and public health officials to explain the challenges patients were experiencing.
Eventually, Melinda traveled to Washington, D.C., to participate in congressional meetings.
She remembers feeling nervous during her first visits.
However, an interaction with former Missouri Senator Roy Blunt helped reinforce the importance of her work.
He encouraged her by explaining that lawmakers need to hear directly from constituents about the challenges affecting their communities.
That experience strengthened Melinda's commitment to advocacy.
Today, she encourages other patients and caregivers to share their stories with elected officials.
If lawmakers don't hear about the problems patients face, they may never fully understand the need for change.
What Is Center for Lyme Action?
Center for Lyme Action is a national advocacy organization working to increase federal funding and advance policy solutions for Lyme disease, alpha-gal syndrome, and other tick-borne conditions.
Its work focuses on:
Increasing federal investment in tick-borne disease research
Improving diagnostic tools and treatment options
Supporting prevention and public health surveillance
Educating members of Congress
Advocating for patients and caregivers
Strengthening state-level advocacy networks
Encouraging collaboration among researchers, healthcare professionals, and policymakers
Melinda explains that Center for Lyme Action began with approximately 30–40 advocates participating in its early congressional outreach efforts.
By the 2025 ILADS Conference, she reports that the network had grown to more than 10,000 advocates nationwide.
She now helps organize and strengthen those state-level teams.
The organization's goal is to turn individual patient experiences into coordinated national advocacy.
How Federal Advocacy Helps Lyme Disease Patients
Rich asks an important question: How does federal advocacy actually help individual patients get better?
Melinda explains that advocacy can influence patient ca
FDA-Cleared Lyme Disease Testing: What's New at IGeneX? – Dr. Jyotsna Shah | LIVE from ILADS
2026/11/08
Could a major breakthrough in Lyme disease testing help more patients get answers sooner? What does FDA clearance mean for people who have struggled with negative Lyme tests despite ongoing symptoms?
In this LIVE from ILADS interview, Tick Boot Camp co-host Rich reunites with Dr. Jyotsna Shah, PhD, President and Laboratory Director of IGeneX, to discuss an important development in Lyme disease diagnostics: FDA clearance of the iDart Lyme IgM and IgG ImmunoBlot test kits.
Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation explores how expanded Borrelia antigen coverage, updated antibody interpretation criteria, and single-step immunoblot testing could improve access to Lyme disease diagnostics.
Dr. Shah also discusses the importance of testing for additional tick-borne infections, including Babesia, Bartonella, Anaplasma, Ehrlichia, and Rickettsia.
The interview addresses several questions that matter to the Lyme disease community:
What does FDA clearance mean for IGeneX Lyme disease testing?
Why are Lyme Western blot bands 31 and 34 important?
How do IGeneX ImmunoBlot tests differ from conventional two-tier Lyme testing?
What is the difference between Lyme Borrelia and tick-borne relapsing fever Borrelia?
Why might someone with Lyme-like symptoms test negative for Lyme disease?
Are Babesia and other tick-borne infections becoming more common?
Will FDA clearance make specialized Lyme testing easier to obtain through insurance?
The biggest takeaway: Dr. Shah believes broader diagnostic tools and improved access to testing could help more patients receive timely answers and appropriate medical care.
Meet Dr. Jyotsna Shah, PhD
Dr. Jyotsna S. Shah, PhD, is President and Laboratory Director of IGeneX, a specialty laboratory based in Milpitas, California, focused on diagnostic testing for Lyme disease and other tick-borne infections.
She has spent decades working to advance laboratory methods for detecting infectious diseases, including Borrelia and Babesia.
Dr. Shah has also been involved in developing and evaluating immunoblot testing, fluorescence in situ hybridization (FISH), and other laboratory techniques.
Her work includes efforts to improve the detection of tick-borne pathogens that may not be identified through commonly used testing approaches.
During this interview, she shares updates on IGeneX's diagnostic technology, FDA clearance, and efforts to expand testing availability.
Learn more about the laboratory at the official IGeneX website.
FDA Clearance for Lyme IgM and IgG ImmunoBlot Tests
The biggest announcement in this interview is the FDA clearance of two Lyme disease immunoblot test kits.
The iDart Lyme IgG ImmunoBlot Kit received FDA clearance in 2024.
The iDart Lyme IgM ImmunoBlot Kit received FDA clearance in 2025.
Both kits are manufactured by ID-FISH Technology, Inc., which has a licensing relationship with IGeneX.
The tests use recombinant antigens from multiple Borrelia species and strains to detect antibodies associated with Lyme disease.
Dr. Shah explains that the FDA clearance process included evaluation of the tests' antigen coverage and interpretation criteria.
She views the clearances as an important milestone for Lyme disease diagnostics.
Importantly, the clearances apply to the specific iDart immunoblot kits, not every test offered by IGeneX.
Read the official announcement about FDA clearance of the Lyme IgM and IgG ImmunoBlots.
What Is a Lyme Disease ImmunoBlot?
An immunoblot is a laboratory test that detects antibodies directed against specific proteins, called antigens.
When someone is exposed to Borrelia bacteria, their immune system may produce antibodies against different bacterial proteins.
An immunoblot measures antibody reactivity to selected antigens.
Dr. Shah discusses two major antibody classes:
IgM antibodies: Often appear earlier during an immune response.
IgG antibodies: Generally develop later and may remain detectable long after an infection.
Both can provide useful information when interpreted in the context of symptoms, exposure history, and other clinical findings.
However, antibody results alone cannot reliably determine whether an infection is currently active, and IgM results can be misleading when used to evaluate symptoms of long duration.
Why Lyme Disease Testing Bands 31 and 34 Matter
One of the most important developments discussed is the inclusion of bands 31 and 34 in the FDA-cleared immunoblot kits.
These bands correspond to Borrelia outer surface proteins:
Band 31: Outer surface protein A, or OspA
Band 34: Outer surface protein B, or OspB
Dr. Shah explains that IGeneX has long considered these bands important when evaluating Lyme disease antibody responses.
She emphasizes that the FDA-cleared tests include these antigens in their interpretation criteria.
The kits use antigen-group interpretation rules rather than simply adopting conventional CDC-associated Western blot band counts.
This is significant because different diagnostic methods may recognize different antibody patterns.
However, no individual band establishes a Lyme disease diagnosis by itself.
Positive antibody findings must be interpreted alongside clinical information, and some bands can have limitations involving cross-reactivity or prior vaccination.
Learn more about the IGeneX FDA-cleared immunoblot technology.
Single-Step Lyme Testing vs. Traditional Two-Tier Testing
Rich asks Dr. Shah to explain how the new immunoblot approach differs from conventional Lyme disease testing.
Traditional standard two-tier testing generally involves two sequential steps.
The first test screens for antibodies.
If the screening result meets the laboratory's criteria, a second test is performed.
Depending on the testing algorithm, that second test may be an immunoblot or another antibody assay.
Dr. Shah explains that the FDA-cleared iDart ImmunoBlot kits are designed to function as stand-alone antibody tests within their authorized intended use.
This means a laboratory does not necessarily need to follow the same two-step workflow when using these particular kits.
She believes this could simplify testing and make broader diagnostic technology available to additional laboratories.
Single-step testing does not eliminate the possibility of false-negative or false-positive results, and test selection should remain guided by clinical circumstances.
Why IGeneX Uses Antigens From Multiple Borrelia Species
Dr. Shah emphasizes the importance of recognizing diversity among Borrelia bacteria.
Lyme disease is associated with multiple Borrelia species, including species found in North America and Europe.
Different species and strains may vary in their antigenic characteristics.
Dr. Shah explains that IGeneX incorporates antigens from multiple species and strains to broaden antibody recognition.
She describes the laboratory's approach as particularly relevant for patients with potential exposure in different geographic regions.
The conversation also distinguishes Lyme disease Borrelia from tick-borne relapsing fever Borrelia.
These are related groups of bacteria, but they are associated with distinct infections and require appropriate diagnostic interpretation.
Lyme Borrelia vs. Tick-Borne Relapsing Fever Borrelia
During the interview, Dr. Shah describes IGeneX testing for two different groups of Borrelia.
Lyme disease Borrelia: She discusses testing that incorporates antigens representing nine Borrelia species associated with Lyme disease.
Tick-borne relapsing fever Borrelia: She describes a separate testing approach involving eight species.
Together, these represent 17 species considered across the two testing categories discussed in the interview.
Dr. Shah emphasizes that patients with similar symptoms may have different infections.
She also explains that some people with tick-borne relapsing fever Borrelia may not describe the classic recurring fever pattern traditionally associated with the disease.
An important distinction is that the FDA-cleared Lyme ImmunoBlot kits should not be described as one FDA-cleared test that detects all 17 species.
The interview discusses separate Lyme disease and relapsing fever testing categories.
Could Tick-Borne Relapsing Fever Be Missed in Patients With Lyme-Like Symptoms?
Dr. Shah describes her laboratory's experience evaluating patients who have symptoms suggestive of tick-borne illness but negative Lyme disease testing.
She explains that some have shown evidence of exposure to relapsing fever Borrelia.
The conversation also touches on laboratory findings involving selected patients reporting Morgellons symptoms.
Dr. Shah describes identifying relapsing fever Borrelia-related findings in some of these patients.
These observations are part of her laboratory experience and do not establish that relapsing fever Borrelia causes Morgellons or explains persistent symptoms in all patients.
They do, however, highlight why clinicians may consider alternative diagnoses when evaluating unexplained symptoms and relevant exposure histories.
Why Lyme Disease Testing Should Consider Co-Infections
Rich and Dr. Shah discuss the growing recognition of infections that can occur alongside Lyme disease.
A tick may carry more than one pathogen, and people may also experience multiple exposures over time.
Dr. Shah explains that patients with suspected tick-borne illness may need evaluation for additional pathogens depending on their symptoms and risk factors.
She discusses several groups of organisms:
Borrelia: Bacteria associated with Lyme disease and relapsing fever.
Babesia: Parasites that infect red blood cells and cause babesiosis.
Bartonella: Bacteria associated with several human diseases, although the role of ticks in transmitting human Bartonella infection remains unproven.
Anaplasma: Bacteria responsible for anaplasmosis.
Ehrlichia: Bacte
From Bed-Bound to Ms Great Britain: Kirstie Haysman’s Lyme Disease Recovery Story
2026/11/07
Read transcript
Kirstie Haysman went from being bed-bound, wheelchair-dependent, unable to care for herself, and wondering whether she would ever recover to walking across a pageant stage and becoming Ms Great Britain 2025/26.
But the crown represents much more than a pageant victory.
In this deeply personal episode of the Tick Boot Camp Podcast, Kirstie shares the decades-long health journey that preceded it: unexplained symptoms beginning in childhood, multiple diagnoses, years of immunosuppressive treatment, debilitating joint and neurological symptoms, frightening intrusive thoughts, psychiatric hospitalization, and encounters with more than 40 doctors before Lyme disease finally entered the conversation.
Kirstie takes listeners through the moment a stranger in a hospital waiting room asked a life-changing question — “Do you think you’ve got Lyme disease?” — and how that question ultimately led her to Mexico, Dr. Omar Morales, testing for Lyme and other tick-borne infections, and the validation she had spent years searching for.
Her story does not end with diagnosis or antimicrobial treatment. Kirstie describes the many approaches she explored, the enormous financial and emotional cost of chronic illness, and why nervous-system regulation, self-hypnosis, visualization, purpose, and changing the story she told herself eventually became important pieces of her personal recovery.
Today, Kirstie is using the visibility that comes with being Ms Great Britain to advocate for people with Lyme disease and other complex chronic illnesses — including her own daughter.
Years of Symptoms and Misdiagnosis
Looking back, Kirstie remembers being an unwell child with chronic exhaustion, recurring infections, severe “growing pains,” insomnia, low iron, and other unexplained symptoms.
Her health deteriorated significantly as an adult.
After testing positive for ANA following the birth of her daughter, Kirstie says doctors initially suspected lupus. Over the years, she received or was considered for numerous diagnoses, including rheumatoid arthritis, connective tissue disease, Raynaud’s, fibromyalgia, osteopenia, osteoporosis, and other conditions.
She was treated with steroids for approximately 12 years and later received additional immunosuppressive medications. Instead of recovering, Kirstie says she became progressively sicker.
Eventually, the joints in her hands became so damaged that she could no longer perform her work as a chiropodist. She lost her business, her independence, and ultimately her ability to care for herself.
When Lyme Disease Affected Her Brain
Some of the most difficult parts of Kirstie’s illness were neurological and psychiatric.
She describes severe insomnia, panic, OCD symptoms, brain fog, intrusive thoughts, overwhelming anxiety, and periods when she felt as though her own mind was no longer under her control.
At one of her lowest points, she entered a psychiatric hospital because she and her family believed she was experiencing a severe mental health crisis.
Kirstie emphasizes an important distinction: she wanted to live, but was terrified by intrusive thoughts telling her to harm herself.
Her experience is an important reminder that patients experiencing psychiatric or neurological symptoms deserve to be heard, taken seriously, and thoroughly evaluated rather than dismissed.
The Stranger Who Changed Everything
After collapsing during another hospital visit, Kirstie says she felt dismissed by a physician who characterized her symptoms as attention-seeking.
Then another woman in the waiting room approached her with a question Kirstie had never been asked before:
Could this be Lyme disease?
Kirstie had barely heard of Lyme.
She went home and began researching. As she read patient stories and symptom lists, she recognized experiences she had been struggling to explain for years.
When she subsequently requested Lyme testing, Kirstie says she encountered resistance because she did not remember a tick bite or an erythema migrans rash.
That experience ultimately pushed her outside the healthcare system she had relied upon throughout her life.
Traveling to Mexico for Answers
The woman Kirstie met in the hospital was preparing to travel to Mexico for Lyme disease care and encouraged Kirstie to speak with Dr. Omar Morales.
That conversation changed the direction of Kirstie’s journey.
Kirstie describes Dr. Morales as one of the first physicians who listened to her entire history and made her feel that her experiences were real and worth investigating.
She traveled to Mexico, where she says specialty testing identified Lyme disease along with infections including Bartonella, Babesia, and Anaplasma.
Receiving those results brought two very different emotions.
There was relief: after years of searching, Kirstie finally felt she had an explanation.
But there was also fear. She had spent nights reading stories from people who remained chronically ill and suddenly wondered whether she would ever recover — and how she could possibly afford the care she believed she needed.
Tick Boot Camp previously interviewed Dr. Morales about his approach to complex Lyme disease in Lyme Mexico: An Interview with Dr. Omar Morales.
Stem Cells, Plasmapheresis, Ozone and Antibiotics
Kirstie ultimately pursued treatment at another facility in Mexico, where she reports receiving interventions including stem cell procedures, plasmapheresis, and ozone therapy.
She describes experiencing meaningful improvement, including increased energy and changes in the mobility of her severely affected hands.
After returning to the United Kingdom, however, her health declined again.
Kirstie later found a UK physician who prescribed an extended combination antibiotic protocol. She credits that period of treatment with helping resolve some of her most frightening intrusive thoughts and neurological symptoms, although gastrointestinal complications eventually led her to discontinue antibiotics.
Over the course of her illness, Kirstie estimates that she spent approximately £70,000 pursuing recovery.
She experimented with dramatically different diets and explored numerous conventional, integrative, and alternative approaches.
Her experience illustrates a reality familiar to many people with complex chronic illness: the search for answers can become financially, physically, and emotionally consuming.
From Wheelchair and Bed-Bound to Rebuilding Her Life
Despite everything she had tried, Kirstie eventually reached another devastating low.
She describes periods when she could barely move, severe pain throughout her body, swollen joints, weakness and loss of sensation in her legs, bladder problems, and dependence on carers for basic daily activities.
She could no longer work.
She was missing important moments in her daughter's childhood.
And she felt that the person she had once been had disappeared.
That was when Kirstie began examining another part of recovery: her nervous system and the way she thought about her body.
Primal Trust, Nervous-System Regulation and Self-Hypnosis
Kirstie discovered the work of Dr. Cathleen King and Primal Trust, which introduced her to concepts involving nervous-system regulation, limbic system retraining, and moving the body away from a persistent state of perceived danger.
This became an important shift in Kirstie’s personal recovery strategy.
Rather than continually reinforcing the message that her body was broken and needed another intervention, she began practicing self-hypnosis and visualization.
From bed, Kirstie imagined herself walking.
She imagined herself healthy.
And she imagined herself standing on the Miss Great Britain stage while an audience applauded.
She even played recordings of crowds cheering while visualizing that future.
Kirstie is careful to describe this as part of a much larger journey that also included extensive medical treatment. Looking back, she believes she encountered nervous-system work at the point when she was finally ready to embrace it.
Her experiences also inspired her to train as a hypnotherapist and help others explore the relationship between thoughts, emotions, nervous-system regulation, and personal well-being.
Kirstie has now launched Queen of Consciousness, her hypnotherapy website, where listeners can learn more about her work and approach.
Learn more about nervous-system regulation and chronic illness in Tick Boot Camp’s interview with Dr. Cathleen King: Primal Trust.
“Bed Bound to Beauty Queen”
Years earlier, Kirstie had competed in Miss Great Britain after becoming Miss Hertfordshire.
When her illness later became severe and her story received widespread media attention, Miss Great Britain reached out with a message of encouragement: if she recovered enough, she should consider returning.
For someone lying in bed wondering what her future would look like, that invitation became a goal.
Kirstie created a social media identity around “Bed Bound to Beauty Queen” and gave herself 365 days to get back onto the pageant stage.
Progress came gradually.
First came standing.
Then a Zimmer frame.
Then walking outside.
Then a walking stick.
Finally, Kirstie returned to the stage.
In 2024, only months after leaving her wheelchair, she returned to Miss Great Britain and placed second runner-up in the Ms Great Britain category.
One year later, she returned again.
This time, Kirstie Haysman became Ms Great Britain 2025/26.
For Kirstie, the crown represented the future she had visualized during some of the darkest days of her illness.
Turning the Crown Into Lyme Disease Advocacy
Kirstie promised that if she recovered, she would use her voice to help other people facing Lyme disease.
She has made that promise a central part of her reign as Ms Great Britain.
Her advocacy has included speaking at the ILADS European Scientific Conference, traveling to the United States with fellow UK Lyme ad
12 Steps to Healing from Chronic Lyme Disease – Dr. Chris Winfrey on Faith, Trauma & Community | LIVE from ILADS
2026/11/06
What if healing from chronic Lyme disease requires more than finding the right medication? What if learning to stop fighting yourself, reconnect with your purpose, and build meaningful relationships could become an important part of your recovery journey?
In this powerful LIVE from ILADS interview, Tick Boot Camp co-host Rich Johannesen reunites with fan-favorite Dr. Chris Winfrey, MD, a board-certified psychiatrist, psychoanalyst, and ILADS board member, to explore the spiritual, emotional, and psychological dimensions of healing from Lyme disease and complex chronic illness.
Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation introduces Dr. Winfrey's 12 Steps for Chronic Illness, a framework inspired by addiction recovery programs, his professional experience in psychiatry, his personal health journey, and the role faith has played throughout his life.
Dr. Winfrey challenges the belief that healing must always involve fighting harder. Instead, he encourages patients to explore acceptance, surrender, self-compassion, nervous system regulation, meaningful relationships, and community support.
The conversation examines several important questions:
Why can chronic illness leave patients feeling trapped in fight-or-flight mode?
What is the difference between surrendering to reality and giving up on recovery?
How can faith, spirituality, and personal purpose support people facing serious illness?
Why are self-compassion and forgiveness important when chronic illness changes your life?
How can patients rebuild relationships affected by years of suffering?
What can the 12-step recovery model teach people living with Lyme disease?
Dr. Winfrey's central message is that patients deserve more than a life defined by illness. They deserve connection, purpose, compassion, and the opportunity to build a meaningful future while continuing to pursue appropriate medical care.
Meet Dr. Chris Winfrey, MD
Dr. Chris Winfrey, MD, is a board-certified psychiatrist and founder of New Image Wellness, a neuropsychiatric practice in New Jersey.
His work integrates traditional psychiatry, psychoanalysis, functional medicine, environmental medicine, and approaches to complex neurological and psychiatric conditions.
His clinical interests include:
Lyme disease and tick-borne infections
PANS/PANDAS
Neuropsychiatric symptoms
Chronic fatigue and cognitive dysfunction
Mold-related health concerns
Trauma and post-traumatic stress disorder
Brain health and nervous system regulation
The relationship between physical illness and mental health
Dr. Winfrey also serves on the board of ILADS, where he hopes to make complex medical information more understandable and expand awareness of Lyme disease in underserved communities.
He explains that Lyme disease is sometimes incorrectly perceived as affecting only certain racial or socioeconomic groups.
One of his goals is to help make education, resources, and conversations about tick-borne illness more accessible.
Learn more about his background and approach through Tick Boot Camp's featured profile of Dr. Chris Winfrey.
A Tick Boot Camp Fan Favorite Returns
Rich opens the interview by welcoming Dr. Winfrey back to the podcast.
The two originally connected through Tick Boot Camp's LIVE from ILADS interview series.
Despite the relatively short format of their first conference interview, Dr. Winfrey became one of the podcast's most popular guests.
He subsequently joined Tick Boot Camp for a longer conversation about Lyme disease, brain health, psychiatric symptoms, and nervous system recovery.
Rich credits Dr. Winfrey's ability to explain complicated medical concepts in language patients can understand.
This new interview expands on an important subject they had not previously explored in depth: the spiritual dimension of healing.
For more from Dr. Winfrey, listen to:
Episode 521: Lyme Disease, Brain Health, and Nervous System Recovery
Episode 563: At the Frontlines of Chronic Illness – ILADS Expert Panel Webinar
How Dr. Winfrey's Grandmother Shaped His Understanding of Faith
Dr. Winfrey begins by honoring his grandmother.
He shares that he experienced PANDAS during childhood and struggled with behavioral, organizational, and emotional challenges.
While others doubted his future, his grandmother continued to believe in him.
She prayed for him and maintained faith that he could overcome the difficulties he was experiencing.
Dr. Winfrey recalls an especially meaningful childhood memory of his grandmother placing olive oil on his head and praying before he went to school.
Her belief in him became an important part of his understanding of faith, hope, and perseverance.
He credits those early experiences with influencing how he now approaches healing.
What Addiction Recovery Taught Dr. Winfrey About Chronic Illness
Dr. Winfrey explains that his interest in 12-step programs began long before he developed his chronic illness framework.
During his early years, he completed community service at an Alcoholics Anonymous facility.
He listened to people describe their experiences with addiction, recovery, accountability, and personal transformation.
His understanding deepened during medical school, residency, and subsequent professional training.
He also worked as a medical director at a drug and alcohol treatment facility.
Over time, he began recognizing parallels between addiction recovery and the psychological challenges faced by people living with chronic illness.
Both experiences can involve:
Loss of control
Fear and uncertainty
Changes in identity
Shame and isolation
Strained relationships
Difficulty accepting reality
The need for community support
Rebuilding meaning and purpose
Drawing on these observations, Dr. Winfrey developed his 12 Steps for Chronic Illness.
He describes the framework as a way to help patients address the emotional, relational, and spiritual consequences of prolonged illness.
It is a supportive framework rather than a validated medical treatment for Lyme disease.
Fight-or-Flight vs. Rest-and-Digest: Understanding the Nervous System
Before introducing the 12 steps, Dr. Winfrey discusses the autonomic nervous system.
He explains the distinction between two important branches:
The sympathetic nervous system helps the body respond to perceived threats through fight-or-flight responses.
The parasympathetic nervous system supports functions associated with rest, digestion, and recovery.
Dr. Winfrey observes that many people with chronic illness spend significant time feeling threatened, overwhelmed, or constantly on guard.
They may find themselves fighting symptoms, doctors, medications, family members, treatment plans, or the circumstances of their illness.
He compares this experience to struggling in quicksand.
The harder someone fights against every aspect of their circumstances, the more exhausted and overwhelmed they may become.
His message is not that patients should stop advocating for themselves.
Rather, he encourages them to recognize when constant conflict may be adding to their emotional and physical burden.
Stress management and nervous system regulation can support well-being, but patients do not have to achieve a particular emotional state for medical treatment to work. Being stressed, frightened, or overwhelmed does not mean someone is preventing their own recovery.
Dr. Chris Winfrey's 12 Steps for Chronic Illness
The centerpiece of this interview is Dr. Winfrey's 12-step framework.
Each step encourages patients to explore a different part of the chronic illness experience.
Step 1: Acceptance
Recognize that chronic illness has changed your life and that fighting reality can deepen suffering.
Dr. Winfrey begins with acceptance.
He explains that patients may spend years resisting the reality of their circumstances.
They may be angry about their symptoms, frustrated by treatment failures, or grieving the life they had before becoming ill.
These emotions are understandable.
Acceptance does not mean approving of the illness, abandoning treatment, or giving up hope.
It means acknowledging the present situation so that decisions can be made from a clearer understanding of reality.
Dr. Winfrey distinguishes between survival mode and growth.
He believes recognizing what has happened is an important foundation for moving forward.
Step 2: Finding Meaning and Purpose
Believe that life can still hold meaning, peace, and joy, even in the presence of illness.
Dr. Winfrey explains that chronic illness can disrupt a person's sense of identity.
Someone who previously defined themselves through work, parenting, caregiving, or physical activity may struggle when those roles change.
He recalls a patient questioning the purpose of getting better because her children had grown up and she no longer had the responsibilities that once gave her life meaning.
Dr. Winfrey believes patients benefit from identifying a reason to keep moving forward.
Rich connects this idea to Tick Boot Camp's belief that people can discover new aspects of their identity and purpose through the recovery journey.
The discussion emphasizes that meaning does not have to wait until symptoms disappear.
Purpose can evolve alongside illness.
Step 3: Surrender
Stop battling what cannot be controlled and focus on the choices, attitudes, and actions that remain available.
Dr. Winfrey distinguishes surrender from defeat.
He describes surrender as acknowledging that a challenge may be too great to navigate alone.
For patients who have already lost careers, relationships, financial stability, or physical abilities, the idea of giving up anything else can feel unbearable.
Dr. Winfrey encourages patients to consider releasing patterns that may be increasing their suffering.
These might include unrealistic expectations, relentless self-criticism, or the belief that they must handle ever
Morgellons Disease, Lyme & Medical Gaslighting – Cindy Casey-Holman | LIVE from ILADS
2026/11/05
What if you developed painful, non-healing skin lesions, experienced sensations of something crawling beneath your skin, and then were told by a doctor that your symptoms were a psychiatric problem?
In this LIVE from ILADS interview, Tick Boot Camp co-host Rich welcomes Cindy Casey-Holman, RN, Executive Director of the Charles E. Holman Morgellons Disease Foundation, to discuss Morgellons disease, its proposed connection to Lyme disease, emerging research, and the devastating impact of medical dismissal.
Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation explores one of the most controversial and misunderstood conditions discussed within the Lyme disease community.
Cindy is a former critical care nurse who developed Morgellons symptoms while working in California. Despite her medical background, she describes being diagnosed with a psychiatric condition after seeking help for painful skin lesions and unusual skin sensations.
Her husband, Charles E. Holman, became an important advocate during her illness. His support ultimately inspired the creation of a nonprofit foundation dedicated to Morgellons research, education, and patient advocacy.
Throughout the interview, Rich and Cindy explore important questions:
What is Morgellons disease, and what symptoms do patients report?
Is there a connection between Morgellons and Lyme disease?
What have researchers discovered about Borrelia bacteria and skin fibers?
Why do some patients receive psychiatric diagnoses when seeking dermatological care?
What role can research and patient advocacy play in improving medical understanding?
For patients who have experienced unexplained symptoms, social isolation, or dismissive medical encounters, this conversation offers validation, education, and a reminder that their suffering deserves compassionate attention and careful investigation.
Meet Cindy Casey-Holman, RN
Cindy Casey-Holman, RN, is the Executive Director of the Charles E. Holman Morgellons Disease Foundation, a Texas-based nonprofit organization supporting scientific research, education, and advocacy related to Morgellons disease.
Before becoming a patient advocate, Cindy worked as a registered nurse in critical care, including high-acuity intensive care settings.
Her experience with Morgellons changed her life.
After developing persistent skin symptoms, Cindy struggled to obtain answers from medical professionals.
She describes the experience as particularly painful because she had spent her career caring for critically ill patients and working alongside physicians.
Her husband, Charles, became one of her strongest advocates.
When Cindy was too ill to advocate effectively for herself, he helped her navigate the medical system and seek answers.
The foundation was named in his honor.
Today, Cindy works with researchers, healthcare professionals, and patients to improve awareness and understanding of Morgellons disease.
Learn more about Cindy Casey-Holman and the foundation's leadership.
What Is Morgellons Disease?
Morgellons disease is a term used to describe a collection of skin-related symptoms, often involving reports of unusual fibers or filaments associated with skin lesions.
Patients may experience persistent itching, pain, abnormal skin sensations, and wounds that are slow to heal.
Cindy describes Morgellons as a dermopathy, meaning a condition affecting the skin.
During the interview, she explains that some patients develop lesions on their arms, legs, face, scalp, back, or other parts of the body.
She also describes the presence of colored fibers associated with affected skin.
The cause of Morgellons remains scientifically contested.
Some researchers have proposed an infectious association, including a possible connection with Borrelia bacteria. Other investigations have not demonstrated an infectious cause and have examined dermatological, neurological, and psychiatric explanations.
Regardless of the underlying cause, the pain, itching, wounds, and distress reported by patients deserve appropriate medical evaluation.
Common Morgellons Symptoms
Cindy describes several symptoms that patients report.
Painful, Slow-Healing Skin Lesions
One of the most prominent complaints involves skin wounds that may persist for extended periods.
Cindy explains that some lesions can become disfiguring, particularly when they appear on visible areas such as the face.
Severe Itching and Burning
Patients may experience intense itching, irritation, and pain.
These symptoms can interfere with sleep, concentration, and daily activities.
Crawling Sensations Beneath the Skin
Cindy describes sensations that patients compare to something crawling on or beneath their skin.
This type of abnormal sensation is sometimes called formication.
Formication can occur in several medical and neurological conditions and does not, by itself, establish the presence of parasites or infection.
Fibers or Filaments Associated With Skin Lesions
Cindy discusses patients reporting unusual colored fibers within or emerging from affected skin.
The origin and significance of these materials remain disputed in the medical literature.
Emotional and Social Isolation
Visible skin lesions can create significant embarrassment and anxiety.
Cindy explains that some patients avoid social situations because they are concerned about how others will react to their appearance.
The combination of physical symptoms, uncertainty, and stigma can profoundly affect quality of life.
Is Morgellons Disease Connected to Lyme Disease?
One of the interview's central questions concerns the relationship between Morgellons and Lyme disease.
Cindy believes Morgellons may represent a skin manifestation associated with Borrelia infection.
She explains that she was not initially aware of having Lyme disease when her Morgellons symptoms developed.
She also discusses research reporting Borrelia organisms or genetic material in some skin samples from people identified as having Morgellons.
Other microorganisms discussed include:
Bartonella henselae
Helicobacter pylori
Treponema denticola
Cindy believes Borrelia may play a particularly important role.
However, the presence of microbial material in selected research samples does not establish that these organisms cause Morgellons or explain every patient's symptoms.
The proposed connection remains controversial, and larger, independently replicated studies are needed.
For more information about research exploring Morgellons, visit the foundation's research resources.
Could Morgellons Be a Manifestation of Lyme Disease?
Rich raises an important question about medical terminology.
If Morgellons symptoms are associated with Lyme disease in some patients, should Morgellons be classified as a separate condition or considered a manifestation of another illness?
Cindy explains that some advocates and researchers have discussed whether Morgellons might be more appropriately described as a syndrome.
Rich argues that separating Morgellons from Lyme disease could create additional confusion when patients seek medical care.
He worries that clinicians may overlook possible tick-borne infections if they view skin symptoms as unrelated.
Cindy agrees that understanding potential connections is important.
However, Morgellons has not been established as a diagnostic sign of Lyme disease, and not everyone reporting Morgellons symptoms has confirmed Lyme disease.
Determining the appropriate classification requires additional research.
What Are the Fibers Associated With Morgellons?
One of the most unusual features discussed in the interview is the presence of colored fibers or filaments.
Cindy describes how difficult it can be for patients to explain these observations to healthcare professionals.
She believes the fibers are an important part of the condition and should be investigated.
Some published studies have proposed that fibers associated with Morgellons involve biological materials produced within the skin.
Other investigations have identified textile fibers and other environmental materials.
The CDC's investigation of unexplained dermopathy did not identify a common infectious cause among the patients studied.
The disagreement illustrates why carefully designed research, appropriate sampling methods, and independent replication are important.
Morgellons, Medical Gaslighting, and Psychiatric Diagnoses
One of the most emotional portions of the interview concerns Cindy's experiences seeking medical care.
She recalls visiting a dermatologist while experiencing severe skin symptoms.
Despite her professional background as an intensive care nurse, she says she was diagnosed with delusional parasitosis.
Cindy describes feeling devastated.
She had spent years caring for patients, trusting medical professionals, and working within the healthcare system.
Suddenly, she found herself questioning whether her own concerns would be taken seriously.
She also recalls reviewing medical records that suggested her husband shared her alleged delusion.
For Cindy, these experiences were deeply damaging.
She believes they contributed to the isolation and frustration experienced by many Morgellons patients.
The interview highlights why clinicians should approach unexplained symptoms with compassion, conduct appropriate evaluations, and communicate diagnoses respectfully.
Psychiatric and neurological conditions are legitimate medical conditions that also deserve evidence-based treatment. A psychiatric diagnosis should never be used as an excuse to dismiss physical suffering or avoid evaluating other possible causes.
When Medical Professionals Become Patients
Rich explores why Cindy's experience may have been especially traumatic because she was a nurse.
As a critical care professional, Cindy was accustomed to working with physicians and caring for patients experiencing life-threat
How to Find the Right Lyme Disease Doctor: Integrative Medicine & Patient Advocacy – Dr. Marina Rasnow-Hill | LIVE from ILADS
2026/11/04
What happens when you're living with chronic Lyme disease, your symptoms are real, but your doctor doesn't have all the answers? And what can patients and physicians do to build a better relationship that leads to better care?
In this LIVE from ILADS interview, Tick Boot Camp co-host Rich welcomes Dr. Marina Rasnow-Hill, MD, a board-certified family and integrative medicine physician, to explore the challenges of treating complex chronic illness, the limitations of traditional medical training, and the importance of building a healthy doctor-patient relationship.
Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation explores why patients with Lyme disease, chronic fatigue, long COVID, mold-related health concerns, and other complex conditions may struggle to find answers.
Dr. Rasnow-Hill shares how her own health challenges led her beyond conventional medical training to explore integrative medicine, acupuncture, herbal therapies, and individualized approaches to chronic illness.
Rich and Dr. Rasnow-Hill also examine a topic that rarely receives enough attention: the responsibilities, expectations, vulnerabilities, and communication challenges on both sides of the doctor-patient relationship.
The conversation concludes with practical advice for patients who want to prepare for appointments, advocate for themselves, and find healthcare professionals who will work collaboratively with them.
Meet Dr. Marina Rasnow-Hill, MD
Dr. Marina Rasnow-Hill, MD, is a California-based physician with approximately 20 years of experience in medicine.
She began her career in family medicine before transitioning toward integrative medicine.
Her professional background includes board certifications in family medicine, integrative medicine, lifestyle medicine, obesity medicine, and medical acupuncture.
Dr. Rasnow-Hill also completed training through the Institute for Functional Medicine.
During the interview, she explains that she has focused exclusively on integrative medicine for approximately seven years.
She currently offers telehealth consultations in six western states: California, Washington, Nevada, Arizona, Colorado, and Idaho.
Her clinical interests include chronic fatigue, chronic pain, immune health, gastrointestinal health, and complex chronic illness.
Learn more through her Institute for Functional Medicine practitioner profile.
Why an Integrative Medicine Physician Attended ILADS
Dr. Rasnow-Hill explains that although she has been involved with ILADS for years, the 2025 conference was her first opportunity to attend in person.
She traveled from California to San Antonio to learn from clinicians and researchers working with Lyme and other tick-borne diseases.
She describes herself as a lifelong learner who continually looks for ways to improve patient care.
Dr. Rasnow-Hill explains that she already works with patients experiencing Lyme disease and other complex illnesses, but wants to continue expanding her knowledge.
Her motivation is practical: she attends medical conferences with specific patients in mind, looking for information that may help guide their future care.
Treating Complex Chronic Illness One Layer at a Time
One of Dr. Rasnow-Hill's biggest takeaways from ILADS involves recognizing that complex chronic illness may require evaluating multiple contributing conditions.
She discusses patients with overlapping concerns involving:
Lyme disease and other tick-borne infections
Chronic fatigue
Long COVID
Mold-related health concerns
Immune dysfunction
Other medical conditions that may complicate recovery
Rather than assuming that one diagnosis explains every symptom, she emphasizes the importance of reassessing the patient's condition as new information becomes available.
Dr. Rasnow-Hill also discusses conference presentations involving antifungal medications, antiviral therapies, and herbal approaches.
These interventions require appropriate medical indications, and their effectiveness varies by condition.
Her broader message is that clinicians should remain curious and willing to reconsider their approach when a patient's progress is limited.
From Conventional Medicine to Integrative Medicine
Rich asks Dr. Rasnow-Hill why she chose to pursue integrative medicine after completing conventional medical training.
She explains that her interest began early in her career.
Even while practicing traditional medicine, she incorporated acupuncture into patient care.
She recalls carrying acupuncture needles in her coat pocket so she could offer treatment when appropriate.
Her interest in complementary approaches was also influenced by her upbringing.
Dr. Rasnow-Hill grew up in a family that was open to what would now be called integrative or complementary medicine.
However, her own health challenges played an especially important role.
She describes experiencing medical problems that were not being adequately addressed through the approaches available to her.
Those experiences encouraged her to explore additional training.
She also began recognizing similar frustrations among her patients.
What Is Integrative Medicine?
Integrative medicine combines conventional medical care with selected complementary approaches when appropriate.
Depending on the condition and available evidence, these may include:
Nutrition and lifestyle interventions
Acupuncture
Stress management
Physical activity and rehabilitation
Selected herbal or botanical therapies
Other supportive interventions
Dr. Rasnow-Hill believes this broader perspective can be valuable when caring for patients with complex medical histories.
She explains that conventional medical education often emphasizes structured diagnostic and treatment frameworks.
While these frameworks are essential, she believes clinicians also need to understand the individual circumstances of the person receiving care.
Importantly, integrative medicine should not mean replacing proven treatments with unvalidated alternatives.
The goal is to consider evidence, patient preferences, safety, and the full clinical picture.
Why Medical School May Not Prepare Doctors for Every Chronic Illness
Rich and Dr. Rasnow-Hill discuss the challenges physicians face when treating conditions that do not fit neatly into established diagnostic categories.
Dr. Rasnow-Hill explains that medical school provides extensive scientific and clinical training.
However, she believes some important aspects of caring for people with complex chronic illness receive less attention.
These include:
Navigating diagnostic uncertainty
Managing complicated symptom patterns
Building long-term therapeutic relationships
Addressing emotional and social concerns
Understanding patient experiences
Recognizing the limits of existing medical knowledge
She explains that postgraduate education allowed her to explore subjects that were not central to her original medical training.
Her experience reinforces the importance of continuing medical education and professional curiosity.
What Happens When Doctors Don't Have All the Answers?
One of the most compelling parts of the interview focuses on the emotional challenges physicians face when they cannot explain or resolve a patient's symptoms.
Rich observes that many physicians have spent much of their lives succeeding academically and solving difficult problems.
Patients often expect them to provide clear diagnoses and effective solutions.
But complex chronic illness does not always offer straightforward answers.
Dr. Rasnow-Hill acknowledges that uncertainty can be difficult for clinicians.
She believes an important quality of a good physician is the ability to admit when they do not know something.
Rather than pretending to have every answer, she values doctors who remain curious, seek additional information, and collaborate with patients.
Medical humility is not a weakness. It can be one of the foundations of effective care.
Why Patients Need Confidence and Honesty From Their Doctors
Rich raises an interesting dilemma.
Patients want doctors who are confident and capable.
When someone has been sick for years, hearing a physician express confidence can provide tremendous reassurance.
However, excessive certainty can become problematic when the underlying diagnosis or treatment plan remains unclear.
Dr. Rasnow-Hill agrees that clinicians must balance confidence with honesty.
A physician can communicate competence while acknowledging uncertainty.
The goal is not to promise a cure or guarantee an outcome.
It is to establish trust through clear communication, realistic expectations, and a willingness to work together.
Understanding Medical Gaslighting and Patient Frustration
Rich and Dr. Rasnow-Hill discuss the frustration many patients experience when their symptoms are dismissed or misunderstood.
People living with chronic Lyme disease and other complex conditions may have spent years searching for explanations.
Some have experienced medical encounters that left them feeling unheard, invalidated, or discouraged.
Dr. Rasnow-Hill recognizes how vulnerable patients can feel when seeking help.
She also explains that healthcare professionals may experience uncertainty and frustration when they cannot determine what is causing a patient's symptoms.
Understanding both perspectives can support more productive communication.
However, empathy for clinicians does not mean patients must accept dismissive behavior or inadequate care.
Patients deserve to have their symptoms taken seriously, their concerns evaluated, and their questions answered respectfully.
Why the Doctor-Patient Relationship Is a Partnership
A central theme of the interview is that effective healthcare requires collaboration.
Rich compares the doctor-patient relationship to other important relationships in life.
Both parties have responsibilities.
Physicians must listen carefully, communi
Sequential Antibiotic Therapy for Chronic Lyme Disease – Dr. Louis Teulières | LIVE from ILADS
2026/11/03
Could changing how antibiotics are administered help address some of the biggest challenges in treating chronic and disseminated Lyme disease? What if the timing, combination, and delivery of antibiotics matter as much as the medications themselves?
In this LIVE from ILADS interview, Tick Boot Camp co-host Rich reunites with Dr. Louis C. Teulières, MD, PhD, a French physician and Lyme disease researcher, to explore his approach to sequential antibiotic therapy, Borrelia persistence, biofilms, neurological Lyme disease, antibiotic combinations, and treatment-related inflammation.
Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation follows Dr. Teulières' presentation, Antibiotic Rotational Combination Sequential Therapies in Chronic and Disseminated Disease TBD.
Dr. Teulières challenges conventional approaches to prolonged antibiotic treatment and explains why he believes carefully structured treatment sequences may offer advantages for selected patients with complex tick-borne illnesses.
Rather than administering antibiotics continuously for extended periods, he describes a strategy involving shorter treatment windows, planned breaks, and carefully selected antibiotic combinations.
He also discusses the importance of matching antibiotics to the tissues affected by infection, considering the blood-brain barrier in neurological Lyme disease, and addressing potential complications involving the gut microbiome, liver, and kidneys.
Rich and Dr. Teulières explore three major questions:
Can sequential antibiotic treatment help clinicians better evaluate treatment responses?
Could planned treatment breaks reduce some of the burdens associated with prolonged antibiotic exposure?
How might clinicians select antibiotic combinations based on bacterial behavior, tissue penetration, and patient symptoms?
The central message is that Lyme disease treatment requires thoughtful clinical decision-making, individualized care, and an understanding of both the potential benefits and risks of antimicrobial therapy.
The sequential antibiotic approach discussed in this interview represents Dr. Teulières' clinical perspective. Its effectiveness and safety compared with established Lyme disease treatment regimens have not been demonstrated in high-quality comparative clinical trials.
Meet Dr. Louis C. Teulières, MD, PhD
Dr. Louis C. Teulières, MD, PhD, is a French physician and researcher whose work includes infectious diseases, complex chronic illness, and approaches to treating Lyme and other tick-borne diseases.
At the 2025 ILADS Conference, Dr. Teulières presented Antibiotic Rotational Combination Sequential Therapies in Chronic and Disseminated Disease TBD.
His presentation explores the use of antibiotic combinations and sequential treatment strategies in patients with complex tick-borne illnesses.
In this interview, he explains his clinical reasoning and discusses why he believes antibiotic timing, medication selection, and treatment intervals deserve greater attention.
Dr. Teulières has been a returning guest on Tick Boot Camp, sharing his perspectives on Lyme disease treatment and the challenges of managing complex infections.
What Is Sequential Antibiotic Therapy for Lyme Disease?
One of the main topics of the interview is Dr. Teulières' proposed sequential antibiotic treatment strategy.
He distinguishes this approach from three other methods of administering antibiotics:
Continuous treatment: Antibiotics are administered without planned breaks for a prescribed period.
Pulsed treatment: Antibiotics are administered intermittently according to a predetermined schedule.
Rotational treatment: Different antibiotics are used in rotation.
Sequential treatment: Dr. Teulières describes administering selected antibiotic combinations for a defined period, followed by a treatment break, with subsequent treatment decisions informed by the patient's response.
During the interview, he discusses an example involving approximately 14 days of antibiotic therapy followed by a planned break of approximately 14 days.
He explains that these intervals may allow clinicians to assess symptoms, review treatment tolerance, and adjust medication combinations.
Dr. Teulières believes the strategy may also provide opportunities for supportive care between antibiotic courses.
However, this specific schedule has not been established as an effective or safer treatment protocol for persistent Lyme disease through controlled clinical trials.
Patients should never independently interrupt or modify prescribed antibiotic treatment.
Why Dr. Teulières Questions Long-Term Continuous Antibiotics
Dr. Teulières explains that he has concerns about prolonged, uninterrupted antibiotic exposure.
He identifies several potential challenges:
Antibiotic-associated adverse effects
Disruption of the intestinal microbiome
Selection of antibiotic-resistant organisms
Difficulty identifying which medications are producing benefits
Possible bacterial survival mechanisms
Additional physical stress during treatment
He believes these concerns warrant consideration of alternative dosing strategies.
His proposed sequential approach is intended to create opportunities for reassessment rather than maintaining the same treatment continuously.
The discussion highlights an important distinction between the established effectiveness of antibiotics for Lyme disease and ongoing debates about additional antimicrobial treatment for persistent symptoms after standard therapy.
Borrelia Persistence: Round Bodies, Biofilms, and Tissue Survival
Rich asks Dr. Teulières about the ability of Borrelia bacteria to survive under challenging conditions.
Dr. Teulières describes several mechanisms that he believes may contribute to bacterial persistence.
Round-Body Forms
He explains that Borrelia can change its morphology under certain environmental conditions.
These changes, sometimes described as round-body forms, have been observed in laboratory research.
Dr. Teulières believes such changes may influence bacterial susceptibility to antimicrobial treatment.
Biofilms
Dr. Teulières also discusses biofilms, which are structured communities of microorganisms surrounded by protective material.
Biofilms can influence how certain microorganisms respond to environmental conditions and antimicrobial exposure.
He raises the possibility that biofilm-related mechanisms could complicate treatment in some patients.
Tissue Localization
The interview explores whether bacteria occupying certain tissues may be less accessible to particular medications.
Dr. Teulières emphasizes that antibiotic selection should account for where an infection is located.
Although Borrelia morphology, biofilm formation, and persister states are active research topics, their role in persistent human Lyme disease symptoms remains incompletely understood.
Laboratory findings do not establish that these mechanisms explain every case of persistent symptoms or that sequential antibiotic treatment overcomes them in patients.
Antibiotic Resistance vs. Bacterial Persistence
Dr. Teulières discusses the possibility that prolonged antibiotic exposure may contribute to the selection of resistant organisms.
He also describes bacterial forms that may survive exposure through mechanisms distinct from conventional antibiotic resistance.
These concepts are related but not identical.
Antibiotic resistance involves mechanisms that allow bacteria to withstand antimicrobial activity.
Antibiotic tolerance or persistence can involve survival during treatment without conventional inherited resistance.
Dr. Teulières believes understanding these differences may help clinicians develop more targeted approaches.
The clinical significance of proposed Borrelia persister forms remains an area of investigation, and the interview does not establish that sequential therapy prevents antibiotic resistance.
Why Dr. Teulières Recommends Treatment Breaks
A central feature of Dr. Teulières' proposed strategy is incorporating planned intervals between antibiotic courses.
He identifies three potential advantages.
1. Allowing Time for Recovery
Dr. Teulières believes treatment breaks may allow patients to recover from some medication-related burdens.
He discusses the liver and kidneys, which play essential roles in processing and eliminating many medications and their metabolites.
He also describes the potential importance of reducing treatment-related discomfort.
2. Evaluating Treatment Response
Dr. Teulières believes a defined treatment period followed by observation may help clinicians determine whether a particular antibiotic combination is producing meaningful changes.
He suggests monitoring whether symptoms improve, remain unchanged, or return during a treatment break.
3. Adjusting Antibiotic Combinations
Sequential treatment may also provide opportunities to reassess the medications being used.
Dr. Teulières proposes adjusting combinations based on the patient's symptoms, suspected infections, and clinical response.
These are the potential advantages he describes, not benefits established through comparative clinical trials.
Scheduled antibiotic breaks have not been proven to provide a specific detoxification benefit or prevent organ injury.
What Happens When Antibiotics Kill Bacteria?
Rich asks Dr. Teulières why some patients experience increased symptoms during antimicrobial treatment.
Dr. Teulières describes how bacterial components can stimulate inflammatory responses as organisms are affected by treatment.
He discusses microbial debris and inflammatory molecules that may contribute to discomfort.
The conversation connects this process to concerns about treatment-related inflammation.
However, symptom worsening during Lyme disease treatment is not automatically evidence of bacterial die-off.
Medication react
Are Lyme Herxheimer Reactions Necessary for Healing? Dr. Casey Kelley | LIVE from ILADS
2026/11/02
Do you have to feel worse before you get better from Lyme disease? And could pushing through severe Herxheimer reactions actually make recovery more difficult?
In this LIVE from ILADS interview, Tick Boot Camp co-host Rich reunites with Dr. Casey Kelley, MD, a functional medicine physician, Lyme disease survivor, and founder of Case Integrative Health in the Chicago area, for an important conversation about Jarisch-Herxheimer reactions, Lyme disease treatment, inflammation, neuroplasticity, and the physical and emotional rehabilitation involved in chronic illness recovery.
Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the discussion explores one of the most debated questions in the Lyme disease community: Is a Herxheimer reaction a necessary sign that treatment is working, or can excessive inflammation interfere with healing?
Dr. Kelley draws on her experience as both a physician and former Lyme disease patient to explain what a Herxheimer reaction is, why symptoms may temporarily worsen during treatment, and why she believes aggressive treatment should not come at the expense of a patient's ability to function.
Rich also introduces Tick Boot Camp's PARM healing framework: Prehabilitation, Assist, Rehabilitate, and Maintenance, which reflects patterns observed through hundreds of patient interviews.
Together, they explore why recovery is rarely linear, why patients need individualized treatment plans, and how nervous system regulation and neuroplasticity may play a role in rehabilitation.
The conversation also celebrates an encouraging milestone: Dr. Kelley is expanding Case Integrative Health to improve patient access to care.
Meet Dr. Casey Kelley, MD
Dr. Casey Kelley, MD, is a functional medicine physician and founder of Case Integrative Health, a Chicago-area practice focused on complex chronic illnesses.
Her clinical interests include Lyme disease and associated infections, immune dysfunction, inflammation, and integrative approaches to patient care.
Dr. Kelley also brings personal experience to her work.
As a former Lyme disease patient, she understands what it feels like to experience debilitating symptoms while appearing outwardly healthy.
During the interview, she recalls living with postural orthostatic tachycardia syndrome (POTS), which made standing and everyday activities difficult.
Her recovery journey helped shape her approach to individualized treatment and rehabilitation.
Dr. Kelley has appeared on Tick Boot Camp multiple times, sharing her experiences and insights into chronic illness recovery.
Case Integrative Health Is Expanding
Rich begins by congratulating Dr. Kelley on the growth of her medical practice.
At the time of the interview, Case Integrative Health had two locations, with plans to open a third.
Dr. Kelley explains that the expansion is primarily about improving access to care.
Her practice offers intravenous therapies, which may require patients to attend appointments regularly.
In the Chicago area, traffic and travel distances can make frequent visits challenging, especially for people experiencing significant fatigue or other chronic symptoms.
She hopes additional locations will reduce some of those barriers.
The conversation highlights an important issue for people with chronic illness: treatment access involves more than finding a healthcare provider. Transportation, physical limitations, appointment frequency, and financial resources can all affect a patient's ability to receive care.
What Is a Jarisch-Herxheimer Reaction?
One of the main topics of the interview is the Jarisch-Herxheimer reaction, commonly called a Herx.
Dr. Kelley explains that the reaction was originally described in patients receiving treatment for syphilis, another infection caused by spirochete bacteria.
A Jarisch-Herxheimer reaction is an acute inflammatory response that can occur after antimicrobial treatment for certain bacterial infections.
In Lyme disease, it may involve a temporary worsening of symptoms after antibiotics are started.
Dr. Kelley describes patients experiencing:
Increased fatigue
Worsening pain
Flu-like symptoms
Generalized discomfort
A feeling resembling a severe hangover
Temporary worsening of existing symptoms
She explains that these reactions can vary considerably between individuals.
Some people experience relatively mild discomfort, while others report more significant symptoms.
Importantly, not every symptom flare during treatment is a Jarisch-Herxheimer reaction. Medication side effects, allergic reactions, disease progression, and other medical complications can also cause worsening symptoms.
Is Herxing a Good Sign That Lyme Treatment Is Working?
Rich asks Dr. Kelley about a common belief in the Lyme disease community: that experiencing a strong Herxheimer reaction means treatment is successfully eliminating an infection.
Some patients believe they need to push through increasingly severe symptoms to make progress.
Dr. Kelley challenges that assumption.
She explains that although inflammatory reactions can occur during treatment, more intense symptoms do not necessarily mean better outcomes.
In her clinical approach, the goal is not to make patients as uncomfortable as possible.
Instead, she tries to balance treatment with the patient's ability to tolerate it.
A severe Herxheimer reaction is not required for successful Lyme disease treatment, and the intensity of a reaction is not a reliable measure of treatment effectiveness.
Dr. Kelley emphasizes that treatment should be individualized and that patients should communicate significant symptom changes to their healthcare professionals.
Can You Recover From Lyme Disease Without Herxing?
Dr. Kelley describes patients who improve without experiencing noticeable Herxheimer reactions.
She acknowledges that some people become concerned when treatment does not cause an obvious symptom flare.
They may wonder whether their medication is working or whether they need a more aggressive approach.
Dr. Kelley explains that she has seen patients make progress without experiencing significant treatment-related worsening.
Her message is encouraging for patients who fear they must endure severe discomfort to recover.
Not experiencing a Herxheimer reaction does not mean treatment is failing.
Likewise, experiencing a reaction does not establish that a treatment is effective.
Treatment response should be evaluated through appropriate clinical assessment rather than symptom worsening alone.
How Much Herxing Is Too Much?
Rich asks Dr. Kelley where she draws the line between manageable treatment-related discomfort and symptoms that warrant changing the treatment plan.
Dr. Kelley explains that she becomes concerned when patients experience severe functional limitations.
Examples include being unable to get out of bed, care for children, complete essential activities, or think clearly.
She believes prolonged, debilitating symptom flares should prompt reassessment rather than automatic encouragement to push harder.
In the interview, Dr. Kelley discusses supportive approaches used in her practice, including measures intended to address discomfort and inflammation.
However, supplements, detoxification products, and other supportive therapies should not be assumed to prevent or treat a true Jarisch-Herxheimer reaction.
Severe, persistent, or unexpected symptoms during treatment require medical evaluation. Patients should not independently stop, increase, or reduce prescribed medications without appropriate clinical guidance.
Why More Aggressive Treatment Is Not Always Better
Dr. Kelley explains that patients differ significantly in their tolerance of medications and other interventions.
Some patients can tolerate complex treatment regimens.
Others experience substantial symptoms or adverse effects from relatively small changes.
She emphasizes that treatment decisions should account for the individual patient's medical history, symptoms, functional status, and response.
Rich asks whether reducing treatment intensity might slow the process of addressing an infection.
Dr. Kelley suggests that treatment intensity and overall recovery are not always the same thing.
Her concern is that excessive symptom burden may create additional challenges that patients must overcome during rehabilitation.
The broader takeaway is that successful care requires balancing effectiveness, safety, and tolerability.
Patients should not interpret worsening symptoms as a reason to continue an intervention without reassessment.
Why Dr. Kelley's Personal Lyme Disease Experience Matters
Rich asks whether physicians who have personally experienced Lyme disease bring a different perspective to patient care.
Dr. Kelley believes lived experience can deepen a clinician's empathy and understanding.
She recalls struggling to sit upright, think clearly, and complete ordinary activities while appearing healthy to others.
Those experiences helped her understand how difficult invisible illnesses can be.
However, she also emphasizes that physicians do not need to have experienced a particular disease to treat it effectively.
She believes the most important qualities include clinical knowledge, compassion, careful observation, and the ability to tailor care to each patient.
Her perspective highlights the value of combining medical expertise with genuine understanding of the patient's experience.
Why Lyme Disease Recovery Is Not Linear
Rich and Dr. Kelley discuss how recovery from prolonged illness often involves periods of progress followed by setbacks.
Some patients improve steadily.
Others experience fluctuating symptoms, changing functional abilities, or periods when additional medical evaluation is needed.
Dr. Kelley explains that these experiences can be especially frustrating when patients expect recovery to follow a predictable timeline.
She encou
Podcast reviews
Read Tick Boot Camp podcast reviews
Liz Goring 2026/02/03
This commnunuty is a must for anyone who has been impacted with Lyme!
As a Lyme warrior who went undiagnosed for over half my life and now works as a Lyme coach, this podcast is so valuable. I truly appreciate the value ...
Trentman183 2025/12/28
Matt and Rich deserve an award
What a gift to the Lyme community! Thank you for diving into every nook and cranny of this disease, gents.
SAM11348SAM 2023/06/23
Best lyme podcast ever!
This is one of those few moments, where you don’t even know where to start! Matt and Rich have put so much time, effort, and thought into each and eve...
sam-sim 2023/05/10
A Treasure Trove
This podcast is a treasure trove of excellent info about Lyme/Lyme syndrome for all those who have to piece things together themselves all too often.
menopausemomma 2022/06/29
Dr Jess
Thank you Matt for the discussion on parasites. Social media has made it concerning that people don’t understand there is a greater root cause than pa...
RangerMer 2022/03/24
Great but way too long
Great information but pleasssse! Please please please edit these down! NO ONE with Lyme has 2.5 hours (even an hour is a stretch) to devote to one pod...
JJDALopes4 2021/12/15
A valuable podcast
This podcast is absolutely amazing! It allows people to share their stories and inspire others to heal and take charge of their Lyme journey. Lyme is ...
oscarmayer 2021/10/22
A much needed resource
Absolutely thrilled that I found this podcast. Chronic Lyme and how to deal with it is not something that most medical professionals know about. This ...
Pprpluspics 2021/04/13
Great podcast
Rich and Matt are excellent interviewers and have a wide range of guests. Their questions are very thorough and include how the interviewee got Lyme, ...
karlimegan 2020/11/28
Great podcast!
So nice to learn and hear from people that understand what I’m going through. It makes me not feel so alone hearing stories I relate to.
Podcast sponsorship advertising
Start advertising on Tick Boot Camp relevant audience podcasts
You may also like to advertise on these Podcasts

4.828116459
Huberman Lab
Scicomm Media

4.240683
To Be The Man
Podcast Heat | Cumulus Podcast Network

4.41511762000
The Ben Shapiro Show
The Daily Wire

4.2155648
TENNIS.com Podcast
TENNIS.com Podcast/Tennis Channel Podcast Network

4.510882780
The Joe Budden Podcast
The Joe Budden Network

4.611699506
The Bulwark Podcast
The Bulwark

4.711532393
Matt and Shane's Secret Podcast
Matt McCusker & Shane Gillis

4.72580183
Smosh Reads Reddit Stories
Smosh

4.975278756
Small Town Murder
James Pietragallo, Jimmie Whisman

4.71326596
Bulwark Takes
The Bulwark

